|
US20040141983A1
(en)
|
1999-03-15 |
2004-07-22 |
Protein Design Labs, Inc. |
Compositions against cancer antigen LIV-1 and uses thereof
|
|
US7244827B2
(en)
|
2000-04-12 |
2007-07-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
US6946129B1
(en)
*
|
1999-06-08 |
2005-09-20 |
Seattle Genetics, Inc. |
Recombinant anti-CD40 antibody and uses thereof
|
|
US20040018194A1
(en)
*
|
2000-11-28 |
2004-01-29 |
Francisco Joseph A. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
US7256257B2
(en)
*
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
EP2163256B1
(en)
|
2001-05-11 |
2015-09-02 |
Ludwig Institute for Cancer Research Ltd. |
Specific binding proteins and uses thereof
|
|
US20110313230A1
(en)
|
2001-05-11 |
2011-12-22 |
Terrance Grant Johns |
Specific binding proteins and uses thereof
|
|
US20050215472A1
(en)
|
2001-10-23 |
2005-09-29 |
Psma Development Company, Llc |
PSMA formulations and uses thereof
|
|
EP2360169B1
(en)
*
|
2001-10-23 |
2015-10-14 |
Psma Development Company, L.L.C. |
PSMA antibodies
|
|
SI2357006T1
(sl)
|
2002-07-31 |
2016-01-29 |
Seattle Genetics, Inc. |
Konjugati zdravil in njihova uporaba za zdravljenje raka, avtoimunske bolezni ali infekcijske bolezni
|
|
US20040081653A1
(en)
*
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
|
WO2004067564A2
(en)
|
2003-01-29 |
2004-08-12 |
Protein Design Labs, Inc. |
Compositions against cancer antigen liv-1 and uses thereof
|
|
EP1594542B1
(en)
*
|
2003-02-20 |
2010-06-30 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer
|
|
US20080025989A1
(en)
*
|
2003-02-20 |
2008-01-31 |
Seattle Genetics, Inc. |
Anti-cd70 antibody-drug conjugates and their use for the treatment of cancer and immune disorders
|
|
EP2266628A3
(en)
|
2003-05-13 |
2012-01-18 |
Novartis Vaccines and Diagnostics, Inc. |
Method of determining the susceptibility to bone meatastases by EPhA2 expression
|
|
BR122018071808B8
(pt)
*
|
2003-11-06 |
2020-06-30 |
Seattle Genetics Inc |
conjugado
|
|
US20050175619A1
(en)
*
|
2004-02-05 |
2005-08-11 |
Robert Duffy |
Methods of producing antibody conjugates
|
|
AU2005216251B2
(en)
*
|
2004-02-23 |
2011-03-10 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
AU2005218642B2
(en)
*
|
2004-03-02 |
2011-04-28 |
Seagen Inc. |
Partially loaded antibodies and methods of their conjugation
|
|
US8288557B2
(en)
|
2004-07-23 |
2012-10-16 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
|
CA2583208C
(en)
|
2004-10-15 |
2015-08-25 |
Seattle Genetics, Inc. |
Anti-cd70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US7641903B2
(en)
*
|
2004-10-15 |
2010-01-05 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
US8337838B2
(en)
*
|
2004-10-15 |
2012-12-25 |
Seattle Genetics, Inc. |
Anti-CD70 antibody and its use for the treatment and prevention of cancer and immune disorders
|
|
EP1817336B1
(en)
*
|
2004-11-12 |
2019-01-09 |
Seattle Genetics, Inc. |
Auristatins having an aminobenzoic acid unit at the n terminus
|
|
WO2006071441A2
(en)
|
2004-11-30 |
2006-07-06 |
Curagen Corporation |
Antibodies directed to gpnmb and uses thereof
|
|
US8165517B2
(en)
|
2005-01-19 |
2012-04-24 |
The Trustees Of The University Of Pennsylvania |
Methods for identifying inhibitors of vascular injury
|
|
JP5122441B2
(ja)
|
2005-04-19 |
2013-01-16 |
シアトル ジェネティックス， インコーポレイテッド |
ヒト化抗ｃｄ７０結合剤およびその使用
|
|
USRE47223E1
(en)
|
2005-06-20 |
2019-02-05 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
|
KR20150126978A
(ko)
*
|
2005-06-20 |
2015-11-13 |
피에스엠에이 디벨롭먼트 캄파니, 엘엘씨 |
Ｐｓｍａ 항체-약물 접합체
|
|
ES2585357T3
(es)
|
2005-07-07 |
2016-10-05 |
Seattle Genetics, Inc. |
Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
|
|
US8871720B2
(en)
|
2005-07-07 |
2014-10-28 |
Seattle Genetics, Inc. |
Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
|
|
SG196786A1
(en)
*
|
2005-07-08 |
2014-02-13 |
Elan Pharm Inc |
Preparation of polymer conjugates of therapeutic, agricultural, and food additive compounds
|
|
SI3248613T1
(sl)
*
|
2005-07-18 |
2022-04-29 |
Seagen Inc. |
Konjugati beta-glukuronidni linker-zdravilo
|
|
AU2006294663B2
(en)
*
|
2005-09-26 |
2012-03-22 |
Medarex, Inc. |
Human monoclonal antibodies to CD70
|
|
AR059900A1
(es)
|
2006-03-17 |
2008-05-07 |
Genentech Inc |
Anticuerpos anti-tat226 e inmunoconjugados
|
|
EP2019690A2
(en)
*
|
2006-05-22 |
2009-02-04 |
Elan Pharmaceuticals Inc. |
Preparation of polymer conjugates of vla-4 antagonists via a mitsunobu's reaction
|
|
HRP20140172T1
(hr)
*
|
2006-05-30 |
2014-03-28 |
Genentech, Inc. |
Protutijela i imunokonjugati kao i njihove uporabe
|
|
WO2008025020A2
(en)
*
|
2006-08-25 |
2008-02-28 |
Seattle Genetics, Inc. |
Cd30 binding agents and uses thereof
|
|
CA2667019C
(en)
|
2006-10-27 |
2016-03-29 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
CA2699837C
(en)
|
2006-12-01 |
2017-06-13 |
Seattle Genetics, Inc. |
Variant target binding agents and uses thereof
|
|
IN2009KN02404A
(enExample)
*
|
2006-12-14 |
2015-08-07 |
Medarex Inc |
|
|
MX338185B
(es)
|
2007-01-25 |
2016-04-05 |
Dana Farber Cancer Inst Inc |
Uso de anticuerpos anti-egfr en el tratamiento de enfermedad mediada por egfr mutante.
|
|
PE20081760A1
(es)
|
2007-02-09 |
2009-01-01 |
Genentech Inc |
Anticuerpos anti-robo4 y sus usos
|
|
EP2134854B1
(en)
*
|
2007-03-15 |
2015-04-15 |
Ludwig Institute for Cancer Research Ltd. |
Treatment method using egfr antibodies and src inhibitors and related formulations
|
|
JP5779350B2
(ja)
|
2007-03-27 |
2015-09-16 |
シー レーン バイオテクノロジーズ， エルエルシー |
抗体代替軽鎖配列を含む構築物およびライブラリー
|
|
GB0707034D0
(en)
|
2007-04-12 |
2007-05-23 |
St Andrews The |
Compounds
|
|
JP5290276B2
(ja)
|
2007-05-08 |
2013-09-18 |
ジェネンテック， インコーポレイテッド |
システイン改変抗ｍｕｃ１６抗体および抗体−薬物結合体
|
|
CN104383553A
(zh)
|
2007-06-25 |
2015-03-04 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CL2008002085A1
(es)
|
2007-07-16 |
2008-11-21 |
Genentech Inc |
Anticuerpo humanizado anti-cd79b/igbeta/b29; polinucleotido codificacnte, vector, celula huesped; metodo de fabricacion; inmunoconjugado; composicion farmaceutica; uso para tratar cancer; metodo in vitro para determinar presencia de cd79b, oinhibir crecimiento de celulas quqe expresa cd79b; ensayo in vitro para detectar celulas b
|
|
EP2641618A3
(en)
|
2007-07-16 |
2013-10-23 |
Genentech, Inc. |
Humanized anti-CD79B antibodies and immunoconjugates and methods of use
|
|
US20090035848A1
(en)
*
|
2007-08-03 |
2009-02-05 |
Robert Hickey |
Moving bed biofilm reactor (mbbr) system for conversion of syngas components to liquid products
|
|
WO2009023265A1
(en)
|
2007-08-14 |
2009-02-19 |
Ludwig Institute For Cancer Research |
Monoclonal antibody 175 targeting the egf receptor and derivatives and uses thereof
|
|
NZ583931A
(en)
|
2007-08-17 |
2012-06-29 |
Purdue Research Foundation |
Psma binding ligand-linker conjugates and methods for using
|
|
EP3241846B1
(en)
|
2007-10-04 |
2022-02-23 |
ZymoGenetics, Inc. |
B7 family member zb7h6 and related compositions and methods
|
|
AU2008310908B2
(en)
|
2007-10-12 |
2014-01-09 |
Seagen Inc. |
Combination therapy with antibody-drug conjugates
|
|
SI2211904T1
(sl)
|
2007-10-19 |
2016-12-30 |
Seattle Genetics, Inc. |
CD19 vezavna sredstva in njihove uporabe
|
|
CA2705486C
(en)
|
2007-11-19 |
2019-04-02 |
Celera Corporation |
Lung cancer markers and uses thereof
|
|
EP2078492A1
(de)
*
|
2008-01-11 |
2009-07-15 |
Roche Diagnostics GmbH |
Bandkassette für ein medizinisches Handgerät und Blutzuckermesssystem
|
|
CN102083460A
(zh)
|
2008-01-18 |
2011-06-01 |
米迪缪尼有限公司 |
用于位点特异性偶联的半胱氨酸工程化抗体
|
|
CN104650230A
(zh)
|
2008-01-31 |
2015-05-27 |
健泰科生物技术公司 |
抗cd79b抗体和免疫偶联物及使用方法
|
|
CA2718942A1
(en)
|
2008-03-18 |
2009-09-24 |
Seattle Genetics, Inc. |
Auristatin drug linker conjugates
|
|
DK2276509T3
(en)
|
2008-04-11 |
2016-09-19 |
Seattle Genetics Inc |
DETECTION AND TREATMENT OF CANCER IN PANCREAS, ovarian and other cancers
|
|
CN104524590B
(zh)
|
2008-04-30 |
2019-06-21 |
伊缪诺金公司 |
交联剂和它们的用途
|
|
PL2282773T3
(pl)
|
2008-05-02 |
2014-08-29 |
Seattle Genetics Inc |
Sposoby i kompozycje do wytwarzania przeciwciał i pochodnych przeciwciał o obniżonej fukozylacji rdzeniowej
|
|
US8835506B2
(en)
|
2008-06-05 |
2014-09-16 |
Stc.Unm |
Methods and related compositions for the treatment of cancer
|
|
PT2326350E
(pt)
|
2008-09-08 |
2013-12-10 |
Psma Dev Company L L C |
Compostos para matar células cancerosas resistentes a taxano, que expressam psma
|
|
GB0819287D0
(en)
|
2008-10-22 |
2008-11-26 |
Univ Bradford |
Compounds
|
|
UA109633C2
(uk)
|
2008-12-09 |
2015-09-25 |
|
Антитіло людини проти тканинного фактора
|
|
CA2749115C
(en)
|
2009-01-09 |
2022-06-21 |
Seattle Genetics, Inc. |
Weekly dosing regimens for anti-cd30 vc-pab-mmae antibody drug-conjugates
|
|
WO2010096394A2
(en)
|
2009-02-17 |
2010-08-26 |
Redwood Biosciences, Inc. |
Aldehyde-tagged protein-based drug carriers and methods of use
|
|
CA2754531A1
(en)
*
|
2009-03-06 |
2010-09-30 |
Seattle Genetics, Inc. |
Antibody drug conjugates (adc) that bind to 24p4c12 proteins
|
|
US20120128671A1
(en)
|
2009-05-13 |
2012-05-24 |
Lawrence Horowitz |
Neutralizing molecules to influenza viruses
|
|
RS58810B1
(sr)
|
2009-06-03 |
2019-07-31 |
Immunogen Inc |
Metodi konjugacije
|
|
CN102802661B
(zh)
|
2009-06-22 |
2016-01-13 |
米迪缪尼有限公司 |
用于位点特异性偶联的工程改造的Fc区
|
|
US9493578B2
(en)
|
2009-09-02 |
2016-11-15 |
Xencor, Inc. |
Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
|
|
JP2013505944A
(ja)
*
|
2009-09-24 |
2013-02-21 |
シアトル ジェネティックス， インコーポレイテッド |
Ｄｒ５リガンド薬物結合体
|
|
US20110076232A1
(en)
|
2009-09-29 |
2011-03-31 |
Ludwig Institute For Cancer Research |
Specific binding proteins and uses thereof
|
|
EP2486023A4
(en)
|
2009-10-06 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
NZ598791A
(en)
|
2009-10-23 |
2014-05-30 |
Millennium Pharm Inc |
Anti-gcc antibody molecules and related compositions and methods
|
|
RU2015132142A
(ru)
*
|
2009-11-30 |
2015-12-20 |
Дженентек, Инк. |
Композиции и способы для диагностики и лечения опухоли
|
|
PT2510011E
(pt)
|
2009-12-09 |
2014-12-12 |
Inst Nat Santé Et De La Rech Médicale |
Anticorpos monoclonais que se ligam a b7h6 e suas utilizações
|
|
WO2011075185A1
(en)
|
2009-12-18 |
2011-06-23 |
Oligasis |
Targeted drug phosphorylcholine polymer conjugates
|
|
UA115517C2
(uk)
|
2010-02-08 |
2017-11-27 |
Ейдженсіс, Інк. |
Кон'югат антитіло-лікарський засіб (adc), який зв'язується з білком 161p2f10b
|
|
KR20130004579A
(ko)
*
|
2010-02-23 |
2013-01-11 |
제넨테크, 인크. |
종양의 진단 및 치료를 위한 조성물 및 방법
|
|
US9951324B2
(en)
|
2010-02-25 |
2018-04-24 |
Purdue Research Foundation |
PSMA binding ligand-linker conjugates and methods for using
|
|
EP2542576B1
(en)
*
|
2010-03-02 |
2016-04-20 |
Seattle Genetics, Inc. |
Methods for screening antibodies
|
|
EP3372617B1
(en)
|
2010-04-02 |
2024-07-24 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
NZ602932A
(en)
|
2010-04-15 |
2014-08-29 |
Seattle Genetics Inc |
Targeted pyrrolobenzodiazapine conjugates
|
|
KR20130097636A
(ko)
|
2010-04-15 |
2013-09-03 |
올리가시스 |
고분자량 쌍성이온-함유 중합체
|
|
MX368648B
(es)
|
2010-04-15 |
2019-10-09 |
Seattle Genetics Inc |
Pirrolobenzodiazepinas usadas para tratar enfermedades proliferativas.
|
|
CN103119442A
(zh)
|
2010-06-03 |
2013-05-22 |
霍夫曼-拉罗奇有限公司 |
抗体和免疫偶联物的免疫peg成像及其用途
|
|
WO2011156328A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
EP2580243B1
(en)
|
2010-06-09 |
2019-10-16 |
Genmab A/S |
Antibodies against human cd38
|
|
US8722629B2
(en)
|
2010-06-10 |
2014-05-13 |
Seattle Genetics, Inc. |
Auristatin derivatives and use thereof
|
|
RS56599B1
(sr)
|
2010-06-15 |
2018-02-28 |
Genmab As |
Konjugati humanog antitela sa lekom protiv tkivnog faktora
|
|
EP3029066B1
(en)
|
2010-07-29 |
2019-02-20 |
Xencor, Inc. |
Antibodies with modified isoelectric points
|
|
US8987209B2
(en)
|
2010-09-29 |
2015-03-24 |
Seattle Genetics, Inc. |
N-carboxyalkyl-auristatin and the use thereof
|
|
IL319612A
(en)
|
2010-09-29 |
2025-05-01 |
Seagen Inc |
Antibody drug conjugates (ADC) that bind to 191P4D12 proteins
|
|
EP3828205A1
(en)
|
2010-10-01 |
2021-06-02 |
Oxford BioTherapeutics Ltd |
Anti-ror1 antibodies
|
|
WO2012054748A2
(en)
|
2010-10-22 |
2012-04-26 |
Seattle Genetics, Inc. |
Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the pi3k-akt mtor pathway
|
|
CA2819038C
(en)
|
2010-12-06 |
2023-10-17 |
Seattle Genetics, Inc. |
Humanized antibodies to liv-1 and use of same to treat cancer
|
|
NZ610976A
(en)
|
2010-12-20 |
2015-07-31 |
Genentech Inc |
Anti-mesothelin antibodies and immunoconjugates
|
|
JOP20210044A1
(ar)
|
2010-12-30 |
2017-06-16 |
Takeda Pharmaceuticals Co |
الأجسام المضادة لـ cd38
|
|
CN103415621A
(zh)
|
2011-01-14 |
2013-11-27 |
雷德伍德生物科技股份有限公司 |
醛标记免疫球蛋白多肽及其使用方法
|
|
ES2543888T3
(es)
|
2011-03-16 |
2015-08-25 |
Seattle Genetics, Inc. |
N-carboxialquil-auristatinas y su utilización
|
|
JP6130307B2
(ja)
|
2011-03-17 |
2017-05-17 |
ザ ユニバーシティ オブ バーミンガム |
再指向性免疫療法
|
|
AU2012236511B2
(en)
|
2011-03-30 |
2016-04-28 |
Arizona Board Of Regents, For And On Behalf Of, Arizona State University |
Auristatin tyramine phosphate salts and auristatin aminoquinoline derivatives and prodrugs thereof
|
|
EP2699260B1
(en)
|
2011-04-20 |
2024-11-20 |
Genmab A/S |
Bispecifc antibodies against her2
|
|
JP6177231B2
(ja)
|
2011-04-20 |
2017-08-09 |
ゲンマブ エー／エス |
Ｈｅｒ２に対する二重特異性抗体
|
|
CA2833477A1
(en)
|
2011-04-21 |
2012-10-26 |
Seattle Genetics, Inc. |
Novel binder-drug conjugates (adcs) and their use
|
|
US8679767B2
(en)
|
2011-05-12 |
2014-03-25 |
Genentech, Inc. |
Multiple reaction monitoring LC-MS/MS method to detect therapeutic antibodies in animal samples using framework signature peptides
|
|
ES2643694T3
(es)
|
2011-05-19 |
2017-11-23 |
Inserm (Institut National De La Santé Et De La Recherche Medicale) |
Anticuerpos anti-HER3 humanos y sus usos
|
|
JP2014515354A
(ja)
|
2011-05-19 |
2014-06-30 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Ｏｓｗ−１類似体および抱合体、ならびにそれらの使用
|
|
KR20140037105A
(ko)
*
|
2011-05-27 |
2014-03-26 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
UA112434C2
(uk)
|
2011-05-27 |
2016-09-12 |
Ґлаксо Ґруп Лімітед |
Антигензв'язувальний білок, який специфічно зв'язується з всма
|
|
US20140105915A1
(en)
|
2011-05-27 |
2014-04-17 |
Glaxo Group Limited |
Bcma (cd269/tnfrsf17) - binding proteins
|
|
KR102356286B1
(ko)
|
2011-05-27 |
2022-02-08 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EP2717916B1
(en)
*
|
2011-06-10 |
2017-03-08 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EA029797B1
(ru)
|
2011-06-21 |
2018-05-31 |
Иммуноджен, Инк. |
Новые производные майтанзиноида с пептидным линкером и их конъюгаты
|
|
CN103747803B
(zh)
|
2011-06-22 |
2016-10-12 |
国家医疗保健研究所 |
抗axl抗体及其用途
|
|
AU2012273954A1
(en)
|
2011-06-22 |
2014-01-09 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Anti-Axl antibodies and uses thereof
|
|
UA117901C2
(uk)
|
2011-07-06 |
2018-10-25 |
Ґенмаб Б.В. |
Спосіб посилення ефекторної функції вихідного поліпептиду, його варіанти та їх застосування
|
|
WO2013015821A1
(en)
|
2011-07-22 |
2013-01-31 |
The Research Foundation Of State University Of New York |
Antibodies to the b12-transcobalamin receptor
|
|
US9120858B2
(en)
|
2011-07-22 |
2015-09-01 |
The Research Foundation Of State University Of New York |
Antibodies to the B12-transcobalamin receptor
|
|
WO2013016714A1
(en)
|
2011-07-28 |
2013-01-31 |
Sea Lane Biotechnologies |
Sur-binding proteins against erbb3
|
|
WO2013022855A1
(en)
|
2011-08-05 |
2013-02-14 |
Xencor, Inc. |
Antibodies with modified isoelectric points and immunofiltering
|
|
MX341524B
(es)
|
2011-09-20 |
2016-08-24 |
Medimmune Ltd |
Pirrolobenzodiazepinas como compuestos pbd dimericos asimetricos para inclusion en conjugados dirigidos.
|
|
CN108152513B
(zh)
|
2011-09-29 |
2020-07-24 |
西雅图基因公司 |
蛋白偶联的试剂化合物的整体分子量测定
|
|
US12466897B2
(en)
|
2011-10-10 |
2025-11-11 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
|
CA3182462A1
(en)
|
2011-10-10 |
2013-04-18 |
Xencor, Inc. |
A method for purifying antibodies
|
|
US10851178B2
(en)
|
2011-10-10 |
2020-12-01 |
Xencor, Inc. |
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
|
|
EP2751110B1
(en)
|
2011-10-14 |
2017-04-19 |
MedImmune Limited |
Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative and autoimmune diseases
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
AU2012322613B2
(en)
|
2011-10-14 |
2016-04-21 |
Medimmune Limited |
Pyrrolobenzodiazepines and targeted conjugates
|
|
KR101891859B1
(ko)
|
2011-10-14 |
2018-08-24 |
메디뮨 리미티드 |
피롤로벤조디아제핀
|
|
EP2780039B9
(en)
|
2011-11-17 |
2018-04-18 |
Pfizer Inc |
Cytotoxic peptides and antibody drug conjugates thereof
|
|
WO2013085925A1
(en)
*
|
2011-12-05 |
2013-06-13 |
Igenica, Inc. |
Antibody-drug conjugates and related compounds, compositions, and methods
|
|
US9975956B2
(en)
|
2011-12-22 |
2018-05-22 |
I2 Pharmaceuticals, Inc. |
Surrogate binding proteins which bind DR4 and/or DR5
|
|
CA2859755C
(en)
|
2011-12-23 |
2021-04-20 |
Pfizer Inc. |
Engineered antibody constant regions for site-specific conjugation and methods and uses therefor
|
|
EP2793949B1
(en)
|
2011-12-23 |
2018-08-22 |
Innate Pharma |
Enzymatic conjugation of antibodies
|
|
US9081453B2
(en)
|
2012-01-12 |
2015-07-14 |
Synaptics Incorporated |
Single layer capacitive imaging sensors
|
|
US20150011736A1
(en)
|
2012-01-20 |
2015-01-08 |
Sea Lane Biotechnologies, Llc |
Binding molecule conjugates
|
|
EP2812702B1
(en)
|
2012-02-10 |
2019-04-17 |
Seattle Genetics, Inc. |
Diagnosis and management of CD30-expressing cancers
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
GB201203442D0
(en)
|
2012-02-28 |
2012-04-11 |
Univ Birmingham |
Immunotherapeutic molecules and uses
|
|
WO2013130093A1
(en)
|
2012-03-02 |
2013-09-06 |
Genentech, Inc. |
Biomarkers for treatment with anti-tubulin chemotherapeutic compounds
|
|
AR090549A1
(es)
|
2012-03-30 |
2014-11-19 |
Genentech Inc |
Anticuerpos anti-lgr5 e inmunoconjugados
|
|
US9156915B2
(en)
|
2012-04-26 |
2015-10-13 |
Thomas Jefferson University |
Anti-GCC antibody molecules
|
|
US9056910B2
(en)
|
2012-05-01 |
2015-06-16 |
Genentech, Inc. |
Anti-PMEL17 antibodies and immunoconjugates
|
|
CN104662000B
(zh)
|
2012-05-15 |
2018-08-17 |
索伦托医疗有限公司 |
药物偶联物及其偶联方法和用途
|
|
US9504756B2
(en)
|
2012-05-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Self-stabilizing linker conjugates
|
|
KR102557309B1
(ko)
|
2012-05-15 |
2023-07-20 |
씨젠 인크. |
자가-안정화 링커 접합체
|
|
US8822423B2
(en)
*
|
2012-05-17 |
2014-09-02 |
Janssen Biotech, Inc. |
Affinity peptides toward infliximab
|
|
US20130309223A1
(en)
|
2012-05-18 |
2013-11-21 |
Seattle Genetics, Inc. |
CD33 Antibodies And Use Of Same To Treat Cancer
|
|
AU2013266604B2
(en)
|
2012-05-21 |
2016-09-08 |
Genentech, Inc. |
Anti-Ly6E antibodies and immunoconjugates and methods of use
|
|
US9522940B2
(en)
|
2012-05-23 |
2016-12-20 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3
|
|
CA2875989A1
(en)
|
2012-06-08 |
2013-12-12 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
EP2863940A4
(en)
|
2012-06-08 |
2016-08-10 |
Biogen Ma Inc |
Chimeric clotting factors
|
|
EP3693000B1
(en)
|
2012-06-08 |
2022-03-02 |
Bioverativ Therapeutics Inc. |
Procoagulant compounds
|
|
US9732161B2
(en)
|
2012-06-26 |
2017-08-15 |
Sutro Biopharma, Inc. |
Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use
|
|
EP3632462A1
(en)
|
2012-07-06 |
2020-04-08 |
Genmab B.V. |
Dimeric protein with triple mutations
|
|
JP6514103B2
(ja)
|
2012-07-06 |
2019-05-15 |
ゲンマブ ビー．ブイ． |
三重変異を有する二量体タンパク質
|
|
EP2872894B1
(en)
|
2012-07-13 |
2019-04-17 |
Innate Pharma |
Screening of conjugated antibodies
|
|
CN112587658A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
ES2528892T3
(es)
|
2012-07-30 |
2015-02-13 |
Nbe-Therapeutics Llc |
Identificación mediada por trasposición de proteínas de unión o funcionales específicas
|
|
KR20150032886A
(ko)
|
2012-08-02 |
2015-03-30 |
제넨테크, 인크. |
항-etbr 항체 및 면역접합체
|
|
KR20150039818A
(ko)
|
2012-08-02 |
2015-04-13 |
제넨테크, 인크. |
항-etbr 항체 및 면역접합체
|
|
KR102355959B1
(ko)
|
2012-08-23 |
2022-01-27 |
어젠시스 인코포레이티드 |
158p1d7 단백질에 결합하는 항체 약물 컨쥬게이트(ａｄｃ)
|
|
US9682934B2
(en)
|
2012-08-31 |
2017-06-20 |
Sutro Biopharma, Inc. |
Modified amino acids
|
|
EP2906249B1
(en)
|
2012-10-12 |
2018-06-27 |
MedImmune Limited |
Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
|
|
EP2906250B1
(en)
|
2012-10-12 |
2018-05-30 |
ADC Therapeutics SA |
Pyrrolobenzodiazepine-anti-psma antibody conjugates
|
|
SI2906253T1
(sl)
|
2012-10-12 |
2018-11-30 |
Adc Therapeutics Sa |
Konjugati pirolobenzodiazepin-protitelo proti PSMA
|
|
WO2014057122A1
(en)
|
2012-10-12 |
2014-04-17 |
Adc Therapeutics Sàrl |
Pyrrolobenzodiazepine-anti-cd22 antibody conjugates
|
|
US10695433B2
(en)
|
2012-10-12 |
2020-06-30 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
PT2906298T
(pt)
|
2012-10-12 |
2018-12-28 |
Medimmune Ltd |
Conjugados de pirrolobenzodiazepina-anticorpos
|
|
SMT201800346T1
(it)
|
2012-10-12 |
2018-09-13 |
Medimmune Ltd |
Coniugati pirrolobenzodiazepina-anticorpo
|
|
WO2014057074A1
(en)
|
2012-10-12 |
2014-04-17 |
Spirogen Sàrl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
ES2713164T3
(es)
|
2012-10-12 |
2019-05-20 |
Medimmune Ltd |
Pirrolobenzodiazepinas y conjugados de las mismas
|
|
US9662402B2
(en)
*
|
2012-10-16 |
2017-05-30 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
WO2014067960A2
(en)
|
2012-10-30 |
2014-05-08 |
Nerviano Medical Sciences S.R.L. |
Functionalized 9-bromo-camptothecin derivatives
|
|
CA2889764C
(en)
|
2012-11-01 |
2023-10-10 |
Martin Lipp |
An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
|
|
KR101762047B1
(ko)
|
2012-11-05 |
2017-07-27 |
화이자 인코포레이티드 |
스플라이세오스타틴 유사체
|
|
EP2916872B1
(en)
|
2012-11-09 |
2019-02-27 |
Innate Pharma |
Recognition tags for tgase-mediated conjugation
|
|
KR102575825B1
(ko)
|
2012-11-15 |
2023-09-06 |
엔도사이트, 인코포레이티드 |
Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트
|
|
WO2014080251A1
(en)
|
2012-11-24 |
2014-05-30 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
AU2013359506B2
(en)
|
2012-12-10 |
2018-05-24 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
US10226535B2
(en)
|
2012-12-10 |
2019-03-12 |
Mersana Therapeutics, Inc. |
Auristatin compounds and conjugates thereof
|
|
EP2931305B1
(en)
*
|
2012-12-12 |
2018-11-28 |
Promega Corporation |
Compositions and methods for capture of cellular targets of bioactive agents
|
|
EP2931316B1
(en)
|
2012-12-12 |
2019-02-20 |
Mersana Therapeutics, Inc. |
Hydroxyl-polymer-drug-protein conjugates
|
|
TWI716339B
(zh)
*
|
2012-12-21 |
2021-01-21 |
荷蘭商台醫（有限合夥）公司 |
親水性自消耗連接子及彼等之共軛物
|
|
US20150314007A1
(en)
|
2012-12-21 |
2015-11-05 |
Glykos Finland Oy |
Linker-payload molecule conjugates
|
|
EA031025B1
(ru)
|
2012-12-21 |
2018-11-30 |
Сиэтл Дженетикс, Инк. |
Антитела против ntb-a и связанные с ними композиции и способы
|
|
KR20220156667A
(ko)
|
2013-01-10 |
2022-11-25 |
젠맵 비. 브이 |
인간 IgG1 Fc 영역 변이체 및 그의 용도
|
|
CA2898100C
(en)
|
2013-01-14 |
2023-10-10 |
Xencor, Inc. |
Novel heterodimeric proteins
|
|
US9605084B2
(en)
|
2013-03-15 |
2017-03-28 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US10968276B2
(en)
|
2013-03-12 |
2021-04-06 |
Xencor, Inc. |
Optimized anti-CD3 variable regions
|
|
US9701759B2
(en)
|
2013-01-14 |
2017-07-11 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US11053316B2
(en)
|
2013-01-14 |
2021-07-06 |
Xencor, Inc. |
Optimized antibody variable regions
|
|
US10131710B2
(en)
|
2013-01-14 |
2018-11-20 |
Xencor, Inc. |
Optimized antibody variable regions
|
|
US10487155B2
(en)
|
2013-01-14 |
2019-11-26 |
Xencor, Inc. |
Heterodimeric proteins
|
|
WO2014113510A1
(en)
|
2013-01-15 |
2014-07-24 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
|
JP6423804B2
(ja)
|
2013-02-28 |
2018-11-14 |
イミュノジェン・インコーポレーテッド |
細胞結合剤及び細胞毒性剤を含む複合体
|
|
JP6494533B2
(ja)
|
2013-02-28 |
2019-04-03 |
イミュノジェン・インコーポレーテッド |
細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体
|
|
US9562099B2
(en)
|
2013-03-14 |
2017-02-07 |
Genentech, Inc. |
Anti-B7-H4 antibodies and immunoconjugates
|
|
WO2014159835A1
(en)
|
2013-03-14 |
2014-10-02 |
Genentech, Inc. |
Anti-b7-h4 antibodies and immunoconjugates
|
|
US11072812B2
(en)
|
2013-03-15 |
2021-07-27 |
Promega Corporation |
Substrates for covalent tethering of proteins to functional groups or solid surfaces
|
|
KR20150132864A
(ko)
|
2013-03-15 |
2015-11-26 |
애브비 인코포레이티드 |
항체 약물 접합체(adc) 정제
|
|
US10168323B2
(en)
|
2013-03-15 |
2019-01-01 |
Promega Corporation |
Compositions and methods for capture of cellular targets of bioactive agents
|
|
US10858417B2
(en)
|
2013-03-15 |
2020-12-08 |
Xencor, Inc. |
Heterodimeric proteins
|
|
US10106624B2
(en)
|
2013-03-15 |
2018-10-23 |
Xencor, Inc. |
Heterodimeric proteins
|
|
KR102178606B1
(ko)
|
2013-03-15 |
2020-11-13 |
자임워크스 인코포레이티드 |
세포독성 및 유사분열-억제 화합물, 및 이를 사용하는 방법
|
|
US20140286969A1
(en)
|
2013-03-15 |
2014-09-25 |
Abbvie Inc. |
Anti-egfr antibody drug conjugate formulations
|
|
EP2968582B1
(en)
|
2013-03-15 |
2020-07-01 |
Innate Pharma |
Solid phase tgase-mediated conjugation of antibodies
|
|
EP3421495A3
(en)
|
2013-03-15 |
2019-05-15 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
|
US10519242B2
(en)
|
2013-03-15 |
2019-12-31 |
Xencor, Inc. |
Targeting regulatory T cells with heterodimeric proteins
|
|
JP6594855B2
(ja)
|
2013-03-15 |
2019-10-23 |
ゼンコア インコーポレイテッド |
ヘテロ二量体タンパク質
|
|
PL2991683T3
(pl)
|
2013-05-02 |
2020-03-31 |
Glykos Finland Oy |
Koniugaty glikoproteiny lub glikanu z toksycznym ładunkiem
|
|
BR112015029838A2
(pt)
|
2013-05-31 |
2017-09-26 |
Genentech Inc |
anticorpos, composições, ácido nucleico isolado, vetor, célula hospedeira isolada, método de produção de anticorpos, composto, conjugado de anticorpo e antibiótico, processo de elaboração do composto, intermediário entre ligante e antibiótico, método de tratamento de infecções bacterianas e método de matar staphylococcus aureus
|
|
WO2014194030A2
(en)
|
2013-05-31 |
2014-12-04 |
Immunogen, Inc. |
Conjugates comprising cell-binding agents and cytotoxic agents
|
|
KR20160015286A
(ko)
|
2013-05-31 |
2016-02-12 |
제넨테크, 인크. |
항-세포벽 테이코산 항체 및 접합체
|
|
GB201309807D0
(en)
|
2013-05-31 |
2013-07-17 |
Pharma Mar Sau |
Antibody drug conjugates
|
|
US9517276B2
(en)
|
2013-06-04 |
2016-12-13 |
Cytomx Therapeutics, Inc. |
Compositions and methods for conjugating activatable antibodies
|
|
WO2014202773A1
(en)
|
2013-06-20 |
2014-12-24 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
CA2914189C
(en)
|
2013-06-21 |
2023-03-14 |
Innate Pharma |
Enzymatic conjugation of polypeptides
|
|
EP3019522B1
(en)
|
2013-07-10 |
2017-12-13 |
Sutro Biopharma, Inc. |
Antibodies comprising multiple site-specific non-natural amino acid residues, methods of their preparation and methods of their use
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
CN105722534B
(zh)
*
|
2013-08-01 |
2019-05-31 |
艾更斯司股份有限公司 |
结合cd37蛋白的抗体药物偶联物(adc)
|
|
GB2516882A
(en)
|
2013-08-02 |
2015-02-11 |
Univ Bradford |
Tumour-targeted theranostic
|
|
US9552089B2
(en)
|
2013-08-07 |
2017-01-24 |
Synaptics Incorporated |
Capacitive sensing using a matrix electrode pattern
|
|
US10442836B2
(en)
|
2013-08-12 |
2019-10-15 |
Genentech, Inc. |
1-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
|
|
AU2014312215B2
(en)
|
2013-08-28 |
2020-02-27 |
Abbvie Stemcentrx Llc |
Site-specific antibody conjugation methods and compositions
|
|
HK1226081A1
(zh)
|
2013-09-12 |
2017-09-22 |
Halozyme, Inc. |
修饰的抗表皮生长因子受体抗体及其使用方法
|
|
AR097685A1
(es)
|
2013-09-17 |
2016-04-06 |
Genentech Inc |
Métodos de uso de anticuerpos anti-lgr5
|
|
US10042489B2
(en)
|
2013-09-30 |
2018-08-07 |
Synaptics Incorporated |
Matrix sensor for image touch sensing
|
|
US20150091842A1
(en)
|
2013-09-30 |
2015-04-02 |
Synaptics Incorporated |
Matrix sensor for image touch sensing
|
|
US9298325B2
(en)
|
2013-09-30 |
2016-03-29 |
Synaptics Incorporated |
Processing system for a capacitive sensing device
|
|
US9459367B2
(en)
|
2013-10-02 |
2016-10-04 |
Synaptics Incorporated |
Capacitive sensor driving technique that enables hybrid sensing or equalization
|
|
EA032231B1
(ru)
|
2013-10-11 |
2019-04-30 |
Мерсана Терапьютикс, Инк. |
Конъюгаты белок-полимер-лекарственное средство
|
|
WO2015052535A1
(en)
|
2013-10-11 |
2015-04-16 |
Spirogen Sàrl |
Pyrrolobenzodiazepine-antibody conjugates
|
|
CN105813654B
(zh)
|
2013-10-11 |
2019-05-31 |
美国政府(由卫生和人类服务部的部长所代表) |
Tem8抗体及其用途
|
|
WO2015054669A1
(en)
|
2013-10-11 |
2015-04-16 |
Asana Biosciences, Llc |
Protein-polymer-drug conjugates
|
|
CN105745224B
(zh)
|
2013-10-11 |
2019-11-05 |
牛津生物疗法有限公司 |
用于治疗癌症的针对ly75的偶联抗体
|
|
US10010624B2
(en)
|
2013-10-11 |
2018-07-03 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
GB201317981D0
(en)
|
2013-10-11 |
2013-11-27 |
Spirogen Sarl |
Pyrrolobenzodiazepines and conjugates thereof
|
|
EP3055298B1
(en)
|
2013-10-11 |
2020-04-29 |
Sutro Biopharma, Inc. |
Modified amino acids comprising tetrazine functional groups, methods of preparation, and methods of their use
|
|
EP3054985B1
(en)
|
2013-10-11 |
2018-12-26 |
Medimmune Limited |
Pyrrolobenzodiazepine-antibody conjugates
|
|
WO2015057876A1
(en)
|
2013-10-15 |
2015-04-23 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
NZ758050A
(en)
*
|
2013-10-15 |
2024-03-22 |
Seagen Inc |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
US9274662B2
(en)
|
2013-10-18 |
2016-03-01 |
Synaptics Incorporated |
Sensor matrix pad for performing multiple capacitive sensing techniques
|
|
SG11201602249RA
(en)
|
2013-10-18 |
2016-05-30 |
Deutsches Krebsforsch |
Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
|
|
CN105658237B
(zh)
|
2013-10-21 |
2021-03-09 |
基因泰克公司 |
抗Ly6E抗体及使用方法
|
|
US9495046B2
(en)
|
2013-10-23 |
2016-11-15 |
Synaptics Incorporated |
Parasitic capacitance filter for single-layer capacitive imaging sensors
|
|
US9081457B2
(en)
|
2013-10-30 |
2015-07-14 |
Synaptics Incorporated |
Single-layer muti-touch capacitive imaging sensor
|
|
WO2015069922A2
(en)
|
2013-11-06 |
2015-05-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Alk antibodies, conjugates, and chimeric antigen receptors, and their use
|
|
BR112016010336A2
(pt)
|
2013-11-07 |
2017-10-03 |
Inst Nat Sante Rech Med |
Anticorpo anti-humano-her3 alostérico não competitivo com neuregulina, fragmento de anticorpo, sequência de ácido nucleico, vetor, célula hospedeira, composição farmacêutica e método para tratamento de câncer
|
|
EA035171B1
(ru)
|
2013-11-14 |
2020-05-08 |
Эндосайт, Инк. |
Конъюгаты на основе связывающихся с psma лигандов или ингибиторов psma для позитронно-эмиссионной томографии
|
|
KR102306493B1
(ko)
|
2013-11-25 |
2021-09-28 |
씨젠 인크. |
접합을 위한 ｃｈｏ 세포 배양물로부터의 항체 제조
|
|
US10335494B2
(en)
|
2013-12-06 |
2019-07-02 |
Millennium Pharmaceuticals, Inc. |
Combination of aurora kinase inhibitors and anti-CD30 antibodies
|
|
AU2014362238A1
(en)
|
2013-12-13 |
2016-06-09 |
Genentech, Inc. |
Anti-CD33 antibodies and immunoconjugates
|
|
JP6980384B2
(ja)
|
2013-12-16 |
2021-12-15 |
ジェネンテック， インコーポレイテッド |
１−（クロロメチル）−２，３−ジヒドロ−１ｈ−ベンゾ［ｅ］インドール二量体抗体−薬物コンジュゲート化合物、並びに使用及び処置の方法
|
|
TWI846009B
(zh)
|
2013-12-19 |
2024-06-21 |
美商思進公司 |
與標的-藥物結合物併用之亞甲基胺基甲酸酯連接物
|
|
US11116847B2
(en)
|
2013-12-19 |
2021-09-14 |
Seagen Inc. |
Methylene carbamate linkers for use with targeted-drug conjugates
|
|
BR112016015105A8
(pt)
|
2013-12-27 |
2018-04-24 |
Var2 Pharmaceuticals Aps |
conjugados var2csa-droga
|
|
RU2729194C2
(ru)
|
2013-12-27 |
2020-08-05 |
Займворкс Инк. |
Сульфонамидсодержащие связывающие системы для лекарственных конъюгатов
|
|
WO2015103549A1
(en)
|
2014-01-03 |
2015-07-09 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Services |
Neutralizing antibodies to hiv-1 env and their use
|
|
US10548985B2
(en)
|
2014-01-10 |
2020-02-04 |
Birdie Biopharmaceuticals, Inc. |
Compounds and compositions for treating EGFR expressing tumors
|
|
EP3094350B1
(en)
|
2014-01-15 |
2020-03-04 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cartilage targeting agents and their use
|
|
EP3096797A1
(en)
|
2014-01-24 |
2016-11-30 |
F. Hoffmann-La Roche AG |
Methods of using anti-steap1 antibodies and immunoconjugates
|
|
AU2015210578B2
(en)
|
2014-01-29 |
2020-04-16 |
Jiangsu Hengrui Medicine Co., Ltd. |
Ligand-cytotoxic drug conjugate, preparation method therefor, and uses thereof
|
|
FR3017298B1
(fr)
|
2014-02-07 |
2016-03-04 |
Centre Nat Rech Scient |
Conjugues et pro-drogues pour le traitement du cancer et de maladies inflammatoires
|
|
HK1231400A1
(zh)
|
2014-02-11 |
2017-12-22 |
Seattle Genetics, Inc. |
蛋白质的选择性还原
|
|
IL309933A
(en)
*
|
2014-02-17 |
2024-03-01 |
Seagen Inc |
Hydrophilic antibody-drug conjugates
|
|
EP3107576A4
(en)
|
2014-02-21 |
2017-09-06 |
Abbvie Stemcentrx LLC |
Anti-dll3 antibodies and drug conjugates for use in melanoma
|
|
US9798429B2
(en)
|
2014-02-28 |
2017-10-24 |
Synaptics Incorporated |
Guard electrodes in a sensing stack
|
|
PT3122757T
(pt)
|
2014-02-28 |
2023-11-03 |
Hangzhou Dac Biotech Co Ltd |
Ligantes carregados e as suas utilizações em conjugação
|
|
CA2942101A1
(en)
|
2014-03-21 |
2015-09-24 |
Abbvie Inc. |
Anti-egfr antibodies and antibody drug conjugates
|
|
MX385936B
(es)
|
2014-03-28 |
2025-03-11 |
Xencor Inc |
Anticuerpos biespecíficos que se unen a cd38 y cd3.
|
|
US10133421B2
(en)
|
2014-04-02 |
2018-11-20 |
Synaptics Incorporated |
Display stackups for matrix sensor
|
|
US9260478B2
(en)
|
2014-04-04 |
2016-02-16 |
Shanghui Hu |
Potent and efficient cytotoxic peptides and antibody-drug conjugates thereof and their synthesis
|
|
FR3020063A1
(fr)
|
2014-04-16 |
2015-10-23 |
Gamamabs Pharma |
Anticorps humain anti-her4
|
|
US9927832B2
(en)
|
2014-04-25 |
2018-03-27 |
Synaptics Incorporated |
Input device having a reduced border region
|
|
US9690397B2
(en)
|
2014-05-20 |
2017-06-27 |
Synaptics Incorporated |
System and method for detecting an active pen with a matrix sensor
|
|
DK3166638T3
(da)
|
2014-06-13 |
2025-10-06 |
Glykos Finland Oy |
Nyttelagt-polymer-proteinkonjugater
|
|
AU2015273353B2
(en)
|
2014-06-13 |
2020-09-10 |
Tenboron Oy |
Conjugates comprising an anti-EGFR1 antibody
|
|
AU2015276821A1
(en)
|
2014-06-20 |
2017-01-12 |
Abgenomics International Inc. |
Anti-folate receptor aplha (FRA) antibody-drug conjugates and methods of using thereof
|
|
WO2015197919A1
(en)
|
2014-06-25 |
2015-12-30 |
Glykos Finland Oy |
Antibody drug conjugates binding to high-mannose n-glycan
|
|
DK3160513T3
(da)
|
2014-06-30 |
2020-04-06 |
Glykos Finland Oy |
Saccharidderivat af en toksisk payload og antistofkonjugater deraf
|
|
AU2015286569B2
(en)
|
2014-07-11 |
2021-04-15 |
Genmab A/S |
Antibodies binding AXL
|
|
WO2016008112A1
(en)
|
2014-07-16 |
2016-01-21 |
Medshine Discovery Inc. |
Linkers and application towards adc thereof
|
|
WO2016014360A1
(en)
|
2014-07-24 |
2016-01-28 |
Genentech, Inc. |
Methods of conjugating an agent to a thiol moiety in a protein that contains at least one trisulfide bond
|
|
EP3194449A1
(en)
|
2014-07-24 |
2017-07-26 |
Xencor, Inc. |
Rapid clearance of antigen complexes using novel antibodies
|
|
ES3034398T3
(en)
|
2014-08-28 |
2025-08-18 |
Bioatla Inc |
Conditionally active chimeric antigen receptors for modified t-cells
|
|
CN112546238A
(zh)
|
2014-09-01 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
|
KR20230172035A
(ko)
|
2014-09-11 |
2023-12-21 |
씨젠 인크. |
삼차 아민-함유 약물 물질의 표적화된 전달
|
|
GB201416112D0
(en)
|
2014-09-12 |
2014-10-29 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
WO2016040724A1
(en)
|
2014-09-12 |
2016-03-17 |
Genentech, Inc. |
Anti-b7-h4 antibodies and immunoconjugates
|
|
CR20170095A
(es)
|
2014-09-12 |
2017-07-19 |
Genentech Inc |
Anticuerpos anti-cll-1 e inmunoconjugados referencias recíprocas con solicitudes relacionadas
|
|
MX2017003123A
(es)
|
2014-09-12 |
2017-05-12 |
Genentech Inc |
Anticuerpos y conjugados modificados geneticamente con cisteina.
|
|
PE20170935A1
(es)
|
2014-09-12 |
2017-07-13 |
Genentech Inc |
Anticuerpos anti-her2 e inmunoconjugados
|
|
RU2723651C2
(ru)
|
2014-09-17 |
2020-06-17 |
Займворкс Инк. |
Цитотоксические и антимитотические соединения и способы их применения
|
|
EP3262071B8
(en)
|
2014-09-23 |
2022-05-18 |
F. Hoffmann-La Roche AG |
Method of using anti-cd79b immunoconjugates
|
|
GB201416960D0
(en)
|
2014-09-25 |
2014-11-12 |
Antikor Biopharma Ltd |
Biological materials and uses thereof
|
|
GB201419108D0
(en)
|
2014-10-27 |
2014-12-10 |
Glythera Ltd |
Materials and methods relating to linkers for use in antibody drug conjugates
|
|
US10011657B2
(en)
|
2014-10-31 |
2018-07-03 |
Abbvie Biotherapeutics Inc. |
Anti-CS1 antibodies and antibody drug conjugates
|
|
EP3215513B1
(en)
|
2014-11-05 |
2019-05-08 |
Nerviano Medical Sciences S.r.l. |
Functionalized morpholinyl anthracycline derivatives
|
|
SMT202100055T1
(it)
|
2014-11-19 |
2021-03-15 |
Axon Neuroscience Se |
Anticorpi tau umanizzati nella malattia di alzheimer
|
|
CN104609464B
(zh)
*
|
2014-11-21 |
2017-01-04 |
中国科学院电工研究所 |
一种PbS纳米片的制备方法
|
|
US10780096B2
(en)
|
2014-11-25 |
2020-09-22 |
Adc Therapeutics Sa |
Pyrrolobenzodiazepine-antibody conjugates
|
|
US10259887B2
(en)
|
2014-11-26 |
2019-04-16 |
Xencor, Inc. |
Heterodimeric antibodies that bind CD3 and tumor antigens
|
|
MX2017006918A
(es)
|
2014-11-26 |
2018-01-25 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a cd3 y cd38.
|
|
HRP20211273T1
(hr)
|
2014-11-26 |
2021-11-12 |
Xencor, Inc. |
Heterodimerna protutijela koja vežu cd3 i cd20
|
|
BR112017011478A2
(pt)
|
2014-12-03 |
2018-02-27 |
Genentech, Inc. |
composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
|
|
CN107206102A
(zh)
|
2014-12-03 |
2017-09-26 |
豪夫迈·罗氏有限公司 |
抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
|
|
MX2017007629A
(es)
|
2014-12-09 |
2018-05-17 |
Abbvie Inc |
Compuestos inhibidores de bcl-xl que tienen una baja permeabilidad en las celulas y conjugados de anticuerpo-farmaco que los incluyen.
|
|
WO2016094505A1
(en)
|
2014-12-09 |
2016-06-16 |
Abbvie Inc. |
Antibody drug conjugates with cell permeable bcl-xl inhibitors
|
|
EP3229836B1
(en)
|
2014-12-09 |
2019-11-13 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
Human monoclonal antibodies against axl
|
|
EP3237449A2
(en)
|
2014-12-22 |
2017-11-01 |
Xencor, Inc. |
Trispecific antibodies
|
|
US10175827B2
(en)
|
2014-12-23 |
2019-01-08 |
Synaptics Incorporated |
Detecting an active pen using a capacitive sensing device
|
|
US9778713B2
(en)
|
2015-01-05 |
2017-10-03 |
Synaptics Incorporated |
Modulating a reference voltage to preform capacitive sensing
|
|
US10188759B2
(en)
|
2015-01-07 |
2019-01-29 |
Endocyte, Inc. |
Conjugates for imaging
|
|
PE20171185A1
(es)
|
2015-01-14 |
2017-08-22 |
Bristol Myers Squibb Co |
Dimeros de benzodiazepina unidos con puentes de heteroarileno, conjugados de estos, y sus metodos de preparacion y uso
|
|
US9527871B2
(en)
|
2015-01-14 |
2016-12-27 |
Bristol-Myers Squibb Company |
Benzodiazepine dimers, conjugates thereof, and methods of making and using
|
|
GB201501004D0
(en)
|
2015-01-21 |
2015-03-04 |
Cancer Rec Tech Ltd |
Inhibitors
|
|
CA2975383C
(en)
|
2015-01-28 |
2023-09-12 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates comprising dolastatin derivatives
|
|
EP3253419A1
(en)
|
2015-02-02 |
2017-12-13 |
The University of Birmingham |
Targeting moiety peptide epitope complexes having a plurality of t-cell epitopes
|
|
WO2016141387A1
(en)
|
2015-03-05 |
2016-09-09 |
Xencor, Inc. |
Modulation of t cells with bispecific antibodies and fc fusions
|
|
WO2016141230A1
(en)
|
2015-03-05 |
2016-09-09 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
|
TWI719967B
(zh)
|
2015-03-09 |
2021-03-01 |
美商艾澤西公司 |
結合至ｆｌｔ３蛋白之抗體藥物結合物（ａｄｃ）
|
|
CA2976740A1
(en)
|
2015-03-18 |
2016-09-22 |
Seattle Genetics, Inc. |
Cd48 antibodies and conjugates thereof
|
|
US9939972B2
(en)
|
2015-04-06 |
2018-04-10 |
Synaptics Incorporated |
Matrix sensor with via routing
|
|
GB201506411D0
(en)
|
2015-04-15 |
2015-05-27 |
Bergenbio As |
Humanized anti-axl antibodies
|
|
GB201506402D0
(en)
|
2015-04-15 |
2015-05-27 |
Berkel Patricius H C Van And Howard Philip W |
Site-specific antibody-drug conjugates
|
|
CN106188293A
(zh)
*
|
2015-04-17 |
2016-12-07 |
江苏恒瑞医药股份有限公司 |
抗c-Met抗体和抗c-Met抗体-细胞毒性药物偶联物及其医药用途
|
|
EP3091033A1
(en)
|
2015-05-06 |
2016-11-09 |
Gamamabs Pharma |
Anti-human-her3 antibodies and uses thereof
|
|
WO2016180948A1
(en)
|
2015-05-12 |
2016-11-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for labeling, detection and isolation of foxp3+ regulatory t cells, isolated population of foxp3+ regulatory t cells thus obtained and uses thereof
|
|
US10526415B2
(en)
|
2015-05-22 |
2020-01-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Human monoclonal antibodies fragments inhibiting both the Cath-D catalytic activity and its binding to the LRP1 receptor
|
|
US20180134788A1
(en)
|
2015-05-26 |
2018-05-17 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and Pharmaceutical Compositions (NTSR1 Inhibitors) for the Treatment of Hepatocellular Carcinomas
|
|
WO2016189118A1
(en)
|
2015-05-28 |
2016-12-01 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods of prognosis and treatment of patients suffering from acute myeloid leukemia
|
|
CN108603170A
(zh)
|
2015-06-12 |
2018-09-28 |
莱蒂恩技术公司 |
用工程改造的t细胞治疗癌症的方法
|
|
WO2015151078A2
(en)
|
2015-06-15 |
2015-10-08 |
Suzhou M-Conj Biotech Co., Ltd |
Hydrophilic linkers for conjugation
|
|
CA2990030A1
(en)
|
2015-06-23 |
2016-12-29 |
Bristol-Myers Squibb Company |
Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses
|
|
US9715304B2
(en)
|
2015-06-30 |
2017-07-25 |
Synaptics Incorporated |
Regular via pattern for sensor-based input device
|
|
US10095948B2
(en)
|
2015-06-30 |
2018-10-09 |
Synaptics Incorporated |
Modulation scheme for fingerprint sensing
|
|
US9720541B2
(en)
|
2015-06-30 |
2017-08-01 |
Synaptics Incorporated |
Arrangement of sensor pads and display driver pads for input device
|
|
BR112017027498A2
(pt)
|
2015-06-30 |
2018-09-11 |
Seattle Genetics Inc |
anticorpo, ácido nucleico, composto, composição, e, método para tratamento de um paciente com uma doença.
|
|
CA2991805A1
(en)
|
2015-07-10 |
2017-01-19 |
Genmab A/S |
Axl-specific antibody-drug conjugates for cancer treatment
|
|
CN108449940B
(zh)
|
2015-07-12 |
2021-06-08 |
杭州多禧生物科技有限公司 |
与细胞结合分子的共轭偶联的桥连接体
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
ES2860988T3
(es)
|
2015-07-22 |
2021-10-05 |
Inatherys |
Anticuerpos anti-TFR y su uso en el tratamiento de trastornos proliferativos e inflamatorios
|
|
CN205028263U
(zh)
|
2015-09-07 |
2016-02-10 |
辛纳普蒂克斯公司 |
一种电容传感器
|
|
US10037112B2
(en)
|
2015-09-30 |
2018-07-31 |
Synaptics Incorporated |
Sensing an active device'S transmission using timing interleaved with display updates
|
|
US10722593B2
(en)
|
2015-10-02 |
2020-07-28 |
Sirenas Llc |
Anti-cancer compounds and conjugates thereof
|
|
US10392441B2
(en)
|
2015-10-07 |
2019-08-27 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
IL-7R-alpha specific antibodies for treating acute lymphoblastic leukemia
|
|
EP3660044A1
(en)
|
2015-10-09 |
2020-06-03 |
Miltenyi Biotec Technology, Inc. |
Chimeric antigen receptors and methods of use
|
|
WO2017060397A1
(en)
|
2015-10-09 |
2017-04-13 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from melanoma metastases
|
|
EP3362088B1
(en)
|
2015-10-12 |
2020-11-25 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
An agent capable of depleting cd8 t cells for the treatment of myocardial infarction or acute myocardial infarction
|
|
MA43354A
(fr)
|
2015-10-16 |
2018-08-22 |
Genentech Inc |
Conjugués médicamenteux à pont disulfure encombré
|
|
WO2017067944A1
(en)
|
2015-10-19 |
2017-04-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the survival time of subjects suffering from triple negative breast cancer
|
|
EP3165237B1
(en)
*
|
2015-11-03 |
2018-12-19 |
Industrial Technology Research Institute |
Antibody-drug conjugate (adc) and method for forming the same
|
|
ES2873846T5
(en)
|
2015-11-19 |
2025-06-23 |
Revitope Ltd |
Functional antibody fragment complementation for a two-components system for redirected killing of unwanted cells
|
|
CA3006610A1
(en)
|
2015-11-30 |
2017-06-08 |
Abbvie Inc. |
Anti-hulrrc15 antibody drug conjugates and methods for their use
|
|
ES2810755T3
(es)
|
2015-11-30 |
2021-03-09 |
Abbvie Inc |
Conjugados fármaco-anticuerpo anti-lrrc15 humano y métodos para su uso
|
|
ES2919323T3
(es)
|
2015-12-04 |
2022-07-26 |
Seagen Inc |
Conjugados de compuestos de tubulisina cuaternizados
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
JP7058219B2
(ja)
|
2015-12-07 |
2022-04-21 |
ゼンコア インコーポレイテッド |
Ｃｄ３及びｐｓｍａに結合するヘテロ二量体抗体
|
|
US10067587B2
(en)
|
2015-12-29 |
2018-09-04 |
Synaptics Incorporated |
Routing conductors in an integrated display device and sensing device
|
|
CN106933400B
(zh)
|
2015-12-31 |
2021-10-29 |
辛纳普蒂克斯公司 |
单层传感器图案和感测方法
|
|
ES2880731T3
(es)
|
2016-01-08 |
2021-11-25 |
Altrubio Inc |
Anticuerpos anti-PSGL-1 tetravalentes y usos de los mismos
|
|
KR20180101479A
(ko)
|
2016-01-13 |
2018-09-12 |
젠맵 에이/에스 |
항체 및 그의 약물 접합체를 위한 제제
|
|
BR112018014615A2
(pt)
|
2016-01-20 |
2018-12-11 |
The Scripps Research Institute |
composições de anticorpo para ror1 e métodos relacionados
|
|
MX390630B
(es)
*
|
2016-01-25 |
2025-03-21 |
Regeneron Pharma |
Derivados de maitansinoide, conjugados de los mismos y metodos de uso.
|
|
GB201601431D0
(en)
|
2016-01-26 |
2016-03-09 |
Medimmune Ltd |
Pyrrolobenzodiazepines
|
|
CA3011455A1
(en)
|
2016-01-27 |
2017-08-03 |
Sutro Biopharma, Inc. |
Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
|
|
ES2874668T3
(es)
|
2016-02-05 |
2021-11-05 |
Rigshospitalet |
Conjugados anticuerpo-fármaco dirigidos a uPARAP
|
|
GB201602359D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
GB201602356D0
(en)
|
2016-02-10 |
2016-03-23 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
HK1259075A1
(zh)
|
2016-02-17 |
2019-11-22 |
Seattle Genetics, Inc. |
Bcma抗体和其用以治疗癌症和免疫病症的用途
|
|
EP3419655A1
(en)
|
2016-02-27 |
2019-01-02 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Peptide vaccines comprising self-assembling polymer nanoparticles
|
|
EP3423112A4
(en)
|
2016-02-29 |
2020-02-26 |
Madrigal Pharmaceuticals, Inc. |
HSP9 INHIBITOR-ACTIVE CONJUGATES
|
|
EP3423105B1
(en)
*
|
2016-03-02 |
2021-05-05 |
Eisai R&D Management Co., Ltd. |
Eribulin-based antibody-drug conjugates and methods of use
|
|
EP3423457B1
(en)
|
2016-03-04 |
2021-02-17 |
H. Hoffnabb-La Roche Ag |
Process for the preparation of an antibody-rifamycin conjugate
|
|
MA45324A
(fr)
|
2016-03-15 |
2019-01-23 |
Seattle Genetics Inc |
Polythérapie utilisant un adc-liv1 et un agent chimiothérapeutique
|
|
WO2017161206A1
(en)
|
2016-03-16 |
2017-09-21 |
Halozyme, Inc. |
Conjugates containing conditionally active antibodies or antigen-binding fragments thereof, and methods of use
|
|
WO2017162678A1
(en)
|
2016-03-22 |
2017-09-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Humanized anti-claudin-1 antibodies and uses thereof
|
|
AU2017238246B2
(en)
|
2016-03-24 |
2021-04-01 |
The Administrators Of The Tulane Educational Fund |
Conjugates of tacrolimus, their compositions, and their uses
|
|
JP7073266B2
(ja)
|
2016-03-25 |
2022-05-23 |
シージェン インコーポレイテッド |
Ｐｅｇ化薬物リンカー及びその中間体を調製するためのプロセス
|
|
CA3014421C
(en)
|
2016-03-29 |
2022-07-19 |
Toray Industries, Inc. |
Peptide derivative and use thereof
|
|
MA45328A
(fr)
|
2016-04-01 |
2019-02-06 |
Avidity Biosciences Llc |
Compositions acide nucléique-polypeptide et utilisations de celles-ci
|
|
SG11201808994YA
(en)
|
2016-04-15 |
2018-11-29 |
Bioatla Llc |
Anti-axl antibodies, antibody fragments and their immunoconjugates and uses thereof
|
|
EP3448885A4
(en)
|
2016-04-26 |
2020-01-08 |
R.P. Scherer Technologies, LLC |
ANTIBODY CONJUGATES AND METHOD FOR THE PRODUCTION AND USE THEREOF
|
|
GB201607478D0
(en)
|
2016-04-29 |
2016-06-15 |
Medimmune Ltd |
Pyrrolobenzodiazepine Conjugates
|
|
WO2017197045A1
(en)
|
2016-05-11 |
2017-11-16 |
Movassaghi Mohammad |
Convergent and enantioselective total synthesis of communesin analogs
|
|
ES2930255T3
(es)
|
2016-05-13 |
2022-12-09 |
Bioatla Inc |
Anticuerpos anti-Ror2, fragmentos de anticuerpos, sus inmunoconjugados y usos de los mismos
|
|
MX2018014175A
(es)
|
2016-05-17 |
2020-02-07 |
Abbvie Biotherapeutics Inc |
Conjugados de anticuerpo-fármaco anti-cmet y métodos para su uso.
|
|
US20170370906A1
(en)
|
2016-05-27 |
2017-12-28 |
Genentech, Inc. |
Bioanalytical analysis of site-specific antibody drug conjugates
|
|
US10668166B2
(en)
|
2016-05-30 |
2020-06-02 |
Toxinvent Ou |
Antibody-drug-conjugates comprising novel anthracycline-derivatives for cancer treatment
|
|
EP3464280B1
(en)
|
2016-06-06 |
2021-10-06 |
F. Hoffmann-La Roche AG |
Silvestrol antibody-drug conjugates and methods of use
|
|
BR112018075649A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco de anticorpo
|
|
EP3468598A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
WO2017214462A2
(en)
|
2016-06-08 |
2017-12-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
RU2018147224A
(ru)
|
2016-06-08 |
2020-07-14 |
Эббви Инк. |
Конъюгаты антитела к egfr и лекарственного средства
|
|
BR112018075645A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
conjugados de anticorpo fármaco anti-egfr
|
|
IL300274A
(en)
|
2016-06-08 |
2023-04-01 |
Abbvie Inc |
Antibodies against B7–H3 and conjugates of drug and antibody
|
|
EP3468993A1
(en)
|
2016-06-08 |
2019-04-17 |
AbbVie Inc. |
Anti-b7-h3 antibodies and antibody drug conjugates
|
|
JP2019522643A
(ja)
|
2016-06-08 |
2019-08-15 |
アッヴィ・インコーポレイテッド |
抗ｃｄ９８抗体及び抗体薬物コンジュゲート
|
|
JP2019521114A
(ja)
|
2016-06-08 |
2019-07-25 |
アッヴィ・インコーポレイテッド |
抗ｅｇｆｒ抗体薬物コンジュゲート
|
|
FI3468586T3
(fi)
|
2016-06-14 |
2024-10-29 |
Xencor Inc |
Bispesifisiä immuuniaktivaatiota vapauttavia vasta-aineita
|
|
WO2018004338A1
(en)
|
2016-06-27 |
2018-01-04 |
Tagworks Pharmaceuticals B.V. |
Cleavable tetrazine used in bio-orthogonal drug activation
|
|
EP3475304B1
(en)
|
2016-06-28 |
2022-03-23 |
Xencor, Inc. |
Heterodimeric antibodies that bind somatostatin receptor 2
|
|
SG11201900699QA
(en)
|
2016-08-09 |
2019-02-27 |
Seattle Genetics Inc |
Drug conjugates with self-stabilizing linkers having improved physiochemical properties
|
|
CN106674347B
(zh)
*
|
2016-08-16 |
2019-12-13 |
滨州医学院 |
一种新型耳抑素抗体
|
|
US10793632B2
(en)
|
2016-08-30 |
2020-10-06 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
US11453712B2
(en)
|
2016-09-02 |
2022-09-27 |
Lentigen Technology Inc. |
Compositions and methods for treating cancer with DuoCARs
|
|
US11254705B2
(en)
|
2016-09-02 |
2022-02-22 |
Sirenas Llc |
Cyclic peptide analogs and conjugates thereof
|
|
US10517958B2
(en)
|
2016-10-04 |
2019-12-31 |
Zymeworks Inc. |
Compositions and methods for the treatment of platinum-drug resistant cancer
|
|
GB201617466D0
(en)
|
2016-10-14 |
2016-11-30 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
CA3040504A1
(en)
|
2016-10-14 |
2018-04-19 |
Xencor, Inc. |
Il15/il15ra heterodimeric fc-fusion proteins
|
|
MA46660A
(fr)
|
2016-10-18 |
2019-08-28 |
Seattle Genetics Inc |
Administration ciblée d'inhibiteurs de la voie de récupération de nicotinamide adénine dinucléotide
|
|
CA3041254A1
(en)
|
2016-10-19 |
2018-04-26 |
Invenra Inc. |
Antibody constructs
|
|
AU2017351764A1
(en)
|
2016-10-25 |
2019-06-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Monoclonal antibodies binding to the CD160 transmembrane isoform
|
|
CN109890417A
(zh)
|
2016-10-28 |
2019-06-14 |
东丽株式会社 |
癌的治疗和/或预防用药物组合物
|
|
EP3535291A1
(en)
|
2016-11-01 |
2019-09-11 |
Genmab B.V. |
Polypeptide variants and uses thereof
|
|
MY199937A
(en)
|
2016-11-08 |
2023-11-29 |
Regeneron Pharma |
Steroids and protein-conjugates thereof
|
|
CN110099682B
(zh)
|
2016-11-14 |
2023-03-31 |
杭州多禧生物科技有限公司 |
偶联连接体，含有此连接体的细胞结合分子-药物偶联物及其制备和应用
|
|
EP3538221B1
(en)
|
2016-11-14 |
2024-10-09 |
Takeda Pharmaceutical Company Limited |
Pediatric human dosing of the anti-cd30 antibody-drug conjugate brentuximab vedotin
|
|
US11135307B2
(en)
|
2016-11-23 |
2021-10-05 |
Mersana Therapeutics, Inc. |
Peptide-containing linkers for antibody-drug conjugates
|
|
JP7244987B2
(ja)
|
2016-12-14 |
2023-03-23 |
シージェン インコーポレイテッド |
多剤抗体薬物コンジュゲート
|
|
US10864279B2
(en)
|
2016-12-16 |
2020-12-15 |
Industrial Technology Research Institute |
Linker-drug and antibody-drug conjugate (ADC) employing the same
|
|
CN118562004A
(zh)
|
2016-12-16 |
2024-08-30 |
蓝鳍生物医药公司 |
抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法
|
|
BR112019013107A2
(pt)
|
2016-12-22 |
2019-12-17 |
Univ Degli Studi Magna Graecia Catanzaro |
anticorpos, molécula de ligação, receptor de antígeno quimérico, vetor de expressão, composição farmacêutica, linfócito, ácido nucleico, célula de hibridoma, método para a produção do anticorpo monoclonal e usos
|
|
KR102015524B1
(ko)
*
|
2016-12-26 |
2019-08-29 |
인터올리고 주식회사 |
압타머-약물 콘쥬게이트 및 그 용도
|
|
CN106854245A
(zh)
*
|
2016-12-28 |
2017-06-16 |
无锡傲锐东源生物科技有限公司 |
抗cd30蛋白单克隆抗体及其用途
|
|
EP3882265B1
(en)
|
2017-01-09 |
2022-11-02 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-mesothelin immunotherapy
|
|
GB201702031D0
(en)
|
2017-02-08 |
2017-03-22 |
Medlmmune Ltd |
Pyrrolobenzodiazepine-antibody conjugates
|
|
ES2871001T3
(es)
|
2017-02-08 |
2021-10-28 |
Adc Therapeutics Sa |
Conjugados de pirrolobenzodiazepinas y anticuerpos
|
|
WO2018146253A1
(en)
|
2017-02-10 |
2018-08-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway
|
|
HRP20250319T1
(hr)
|
2017-02-16 |
2025-05-09 |
Sonnet BioTherapeutics, Inc. |
Fuzijski proteini s domenom za vezanje na albumin
|
|
US20210330801A1
(en)
|
2017-03-02 |
2021-10-28 |
Cadila Healthcare Limited |
Novel protein drug conjugate formulation
|
|
GB201703876D0
(en)
|
2017-03-10 |
2017-04-26 |
Berlin-Chemie Ag |
Pharmaceutical combinations
|
|
KR102648564B1
(ko)
|
2017-03-24 |
2024-03-19 |
씨젠 인크. |
글루쿠로니드 약물-링커의 제조 공정 및 그 중간물
|
|
CN110997719B
(zh)
|
2017-03-24 |
2020-12-11 |
莱蒂恩技术公司 |
用于用抗cd33免疫疗法治疗癌症的组合物和方法
|
|
ES2955852T3
(es)
|
2017-04-03 |
2023-12-07 |
Hoffmann La Roche |
Anticuerpos de unión a STEAP-1
|
|
JP7284707B2
(ja)
|
2017-04-07 |
2023-05-31 |
ジュノー セラピューティクス インコーポレイテッド |
前立腺特異的膜抗原（ｐｓｍａ）またはその改変型を発現する操作された細胞および関連方法
|
|
WO2018192944A1
(en)
|
2017-04-18 |
2018-10-25 |
Medimmune Limited |
Pyrrolobenzodiazepine conjugates
|
|
CA3064697A1
(en)
|
2017-04-19 |
2018-10-25 |
Bluefin Biomedicine, Inc. |
Anti-vtcn1 antibodies and antibody drug conjugates
|
|
CA3057748A1
(en)
|
2017-04-20 |
2018-10-25 |
Adc Therapeutics Sa |
Combination therapy with an anti-axl antibody-drug conjugate
|
|
JP7425606B2
(ja)
|
2017-04-27 |
2024-01-31 |
シージェン インコーポレイテッド |
四級化ニコチンアミドアデニンジヌクレオチドサルベージ経路阻害剤コンジュゲート
|
|
JOP20190254A1
(ar)
|
2017-04-27 |
2019-10-27 |
Pharma Mar Sa |
مركبات مضادة للأورام
|
|
CA3061467A1
(en)
|
2017-04-28 |
2019-10-24 |
Ajinomoto Co., Inc. |
Compound having affinity substance to soluble protein, cleavable portionand reactive group, or salt thereof
|
|
WO2018209239A1
(en)
|
2017-05-11 |
2018-11-15 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
EP3624854A1
(en)
|
2017-05-16 |
2020-03-25 |
Université de Strasbourg |
Protein-drug conjugates and their use in the treatment of cancers
|
|
KR20200007905A
(ko)
|
2017-05-18 |
2020-01-22 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
JP7366755B2
(ja)
|
2017-05-30 |
2023-10-23 |
ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ オクラホマ |
抗ダブルコルチン様キナーゼ１抗体および使用方法
|
|
CN118994394A
(zh)
|
2017-06-12 |
2024-11-22 |
蓝鳍生物医药公司 |
抗-il1rap抗体和抗体药物缀合物
|
|
ES2988683T3
(es)
|
2017-06-14 |
2024-11-21 |
Adc Therapeutics Sa |
Pautas posológicas para la administración de un CAF anti-CD19
|
|
US20210100912A1
(en)
*
|
2017-06-19 |
2021-04-08 |
Sichuan Baili Pharmaceutical Co. Ltd. |
Antibody-drug conjugate having acidic self-stabilization junction
|
|
WO2018234843A1
(en)
|
2017-06-22 |
2018-12-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of fibrosis with agents capable of inhibiting the activation of mucosal-associated invariant t (mait) cells
|
|
JP7320458B2
(ja)
|
2017-06-22 |
2023-08-03 |
メルサナ セラピューティクス インコーポレイテッド |
薬物担持ポリマースキャフォールドおよびタンパク質－ポリマー－薬物コンジュゲートを製造する方法
|
|
KR102736878B1
(ko)
|
2017-06-23 |
2024-12-05 |
벨로스바이오 인코포레이티드 |
Ror1 항체 면역접합체
|
|
JP2020526584A
(ja)
|
2017-06-28 |
2020-08-31 |
ザ ロックフェラー ユニバーシティー |
抗ｍｅｒｔｋアゴニスト抗体−薬物コンジュゲートおよびその使用
|
|
MA49517A
(fr)
|
2017-06-30 |
2020-05-06 |
Xencor Inc |
Protéines de fusion fc hétérodimères ciblées contenant il-15/il-15ra et domaines de liaison à l'antigène
|
|
US12227567B2
(en)
|
2017-07-25 |
2025-02-18 |
Truebinding, Inc. |
Treating cancer by blocking the interaction of TIM-3 and its ligand
|
|
EP3658588A1
(en)
|
2017-07-26 |
2020-06-03 |
Sutro Biopharma, Inc. |
Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma
|
|
WO2019028051A1
(en)
|
2017-07-31 |
2019-02-07 |
Lentigen Technology, Inc. |
COMPOSITIONS AND METHODS FOR TREATING CANCER BY ANTI-CD19 / CD20 IMMUNOTHERAPY
|
|
MX2020001490A
(es)
|
2017-08-09 |
2020-08-06 |
Juno Therapeutics Inc |
Metodos para producir composiciones de celulas geneticamente modificadas y composiciones relacionadas.
|
|
SG11202000358YA
(en)
|
2017-08-18 |
2020-02-27 |
Medimmune Ltd |
Pyrrolobenzodiazepine conjugates
|
|
US10501539B2
(en)
|
2017-09-15 |
2019-12-10 |
Lentigen Technology Inc. |
Compositions and methods for treating cancer with anti-CD19 immunotherapy
|
|
US10596270B2
(en)
|
2017-09-18 |
2020-03-24 |
Sutro Biopharma, Inc. |
Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates
|
|
IL316538A
(en)
|
2017-10-11 |
2024-12-01 |
Seagen Inc |
Methods of reducing side effects of anti-cd30 antibody drug conjugate therapy
|
|
US11332527B2
(en)
|
2017-10-12 |
2022-05-17 |
Keio University |
Anti AQP3 monoclonal antibody specifically binding to extracellular domain of aquaporin 3 (AQP3) and use thereof
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
EP4279584A3
(en)
|
2017-10-16 |
2024-03-06 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-cd22 immunotherapy
|
|
CN107759699A
(zh)
*
|
2017-10-18 |
2018-03-06 |
银丰生物工程集团有限公司 |
靶向cd30抗原的转基因t细胞及其制备方法与应用
|
|
US20220226439A1
(en)
|
2017-11-01 |
2022-07-21 |
Seagen Inc. |
Methods of reducing side effects of anti-cd30 antibody drug conjugate therapy
|
|
WO2019090110A1
(en)
|
2017-11-03 |
2019-05-09 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-ror1 immunotherapy
|
|
CN111601619A
(zh)
|
2017-11-07 |
2020-08-28 |
里珍纳龙药品有限公司 |
用于抗体药物偶联物的亲水性连接体
|
|
US10981992B2
(en)
|
2017-11-08 |
2021-04-20 |
Xencor, Inc. |
Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors
|
|
WO2019094637A1
(en)
|
2017-11-08 |
2019-05-16 |
Xencor, Inc. |
Bispecific and monospecific antibodies using novel anti-pd-1 sequences
|
|
JP2021504695A
(ja)
*
|
2017-11-22 |
2021-02-15 |
シアトル ジェネティクス インコーポレイティッド |
リガンド−薬物複合体を分析するための酸媒介アッセイ
|
|
EP3717069A1
(en)
|
2017-11-27 |
2020-10-07 |
Purdue Pharma L.P. |
Humanized antibodies targeting human tissue factor
|
|
EA202090922A1
(ru)
*
|
2017-11-29 |
2021-03-09 |
Маджента Терапьютикс, Инк. |
Композиции и способы истощения cd2+ клеток
|
|
US20200283540A1
(en)
|
2017-12-01 |
2020-09-10 |
Seattle Genetics, Inc. |
Humanized anti-liv1 antibodies for the treatment of breast cancer
|
|
US11180552B2
(en)
|
2017-12-01 |
2021-11-23 |
Seagen Inc. |
CD47 antibodies and uses thereof for treating cancer
|
|
US11766455B2
(en)
|
2017-12-14 |
2023-09-26 |
Ezy Biotech Llc |
Subject-specific tumor inhibiting cells and the use thereof
|
|
EP3498293A1
(en)
|
2017-12-15 |
2019-06-19 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Treatment of monogenic diseases with an anti-cd45rc antibody
|
|
KR102722731B1
(ko)
|
2017-12-19 |
2024-10-25 |
젠코어 인코포레이티드 |
조작된 il-2 fc 융합 단백질
|
|
CN111954677A
(zh)
|
2017-12-20 |
2020-11-17 |
莱蒂恩技术公司 |
用于用免疫治疗来治疗hiv/aids的组合物和方法
|
|
US12070506B2
(en)
|
2018-01-08 |
2024-08-27 |
Regeneron Pharmaceuticals, Inc. |
Steroids and antibody-conjugates thereof
|
|
WO2019164987A1
(en)
|
2018-02-20 |
2019-08-29 |
Seattle Genetics, Inc. |
Hydrophobic auristatin f compounds and conjugates thereof
|
|
GB201803342D0
(en)
|
2018-03-01 |
2018-04-18 |
Medimmune Ltd |
Methods
|
|
AU2019232602B2
(en)
|
2018-03-07 |
2025-03-27 |
Forschungsverbund Berlin E.V. |
Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates
|
|
HRP20231280T1
(hr)
|
2018-03-13 |
2024-02-02 |
Zymeworks Bc Inc. |
Anti-her2 biparatopski antitijelo-konjugati lijeka i načini uporabe
|
|
US12281171B2
(en)
|
2018-03-19 |
2025-04-22 |
Bio Ventures, Llc |
Periostin antibodies and methods of using the same
|
|
AU2019240403A1
(en)
|
2018-03-23 |
2020-10-08 |
Seagen Inc. |
Use of antibody drug conjugates comprising tubulin disrupting agents to treat solid tumor
|
|
CN112469477A
(zh)
|
2018-04-04 |
2021-03-09 |
Xencor股份有限公司 |
与成纤维细胞活化蛋白结合的异源二聚体抗体
|
|
EP3552631A1
(en)
|
2018-04-10 |
2019-10-16 |
Inatherys |
Antibody-drug conjugates and their uses for the treatment of cancer
|
|
GB201806022D0
(en)
|
2018-04-12 |
2018-05-30 |
Medimmune Ltd |
Pyrrolobenzodiazepines and conjugates thereof
|
|
BR112020020961A2
(pt)
|
2018-04-17 |
2021-01-19 |
Endocyte, Inc. |
Métodos de tratamento de câncer
|
|
CA3097741A1
(en)
|
2018-04-18 |
2019-10-24 |
Xencor, Inc. |
Tim-3 targeted heterodimeric fusion proteins containing il-15/il-15ra fc-fusion proteins and tim-3 antigen binding domains
|
|
JP2021521784A
(ja)
|
2018-04-18 |
2021-08-30 |
ゼンコア インコーポレイテッド |
ＩＬ−１５／ＩＬ−１５ＲａＦｃ融合タンパク質とＰＤ−１抗原結合ドメインを含むＰＤ−１標的化ヘテロダイマー融合タンパク質およびそれらの使用
|
|
ES2975330T3
(es)
|
2018-05-04 |
2024-07-04 |
Tagworks Pharmaceuticals B V |
Compuestos que comprenden un enlazador para aumentar la estabilidad del trans-cicloocteno
|
|
US11396497B2
(en)
|
2018-05-04 |
2022-07-26 |
New Mexico Tech University Research Park Corporation |
Proteasome inhibitors
|
|
EP3787691A1
(en)
|
2018-05-04 |
2021-03-10 |
Tagworks Pharmaceuticals B.V. |
Tetrazines for high click conjugation yield in vivo and high click release yield
|
|
BR112020022265A2
(pt)
|
2018-05-07 |
2021-02-23 |
Genmab A/S |
método para tratar câncer em um indivíduo, e, estojo.
|
|
CN112739716B
(zh)
|
2018-05-07 |
2025-05-27 |
展马博联合股份有限公司 |
使用抗pd-1抗体与抗组织因子抗体-药物偶联物的组合治疗癌症的方法
|
|
AU2019265703A1
(en)
|
2018-05-09 |
2020-11-19 |
Regeneron Pharmaceuticals, Inc. |
Anti-MSR1 antibodies and methods of use thereof
|
|
JP7398396B2
(ja)
|
2018-06-01 |
2023-12-14 |
ノバルティス アーゲー |
Ｂｃｍａに対する結合分子及びその使用
|
|
WO2019234136A1
(en)
|
2018-06-05 |
2019-12-12 |
King's College London |
Btnl3/8 targeting constructs for delivery of payloads to the gastrointestinal system
|
|
TW202519270A
(zh)
|
2018-06-07 |
2025-05-16 |
美商思進公司 |
喜樹鹼結合物
|
|
KR102880460B1
(ko)
|
2018-06-14 |
2025-11-06 |
아지노모토 가부시키가이샤 |
항체에 대한 친화성 물질 및 생체 직교성 관능기를 갖는 화합물 또는 이의 염
|
|
GB201809746D0
(en)
|
2018-06-14 |
2018-08-01 |
Berlin Chemie Ag |
Pharmaceutical combinations
|
|
KR20210020901A
(ko)
|
2018-06-14 |
2021-02-24 |
아지노모토 가부시키가이샤 |
항체에 대한 친화성 물질, 절단성 부분 및 반응성기를 갖는 화합물 또는 이의 염
|
|
PE20211091A1
(es)
|
2018-07-02 |
2021-06-14 |
Amgen Inc |
Proteina de union al antigeno anti-steap1
|
|
WO2020023871A1
(en)
|
2018-07-27 |
2020-01-30 |
Promega Corporation |
Quinone-containing conjugates
|
|
LT3849614T
(lt)
|
2018-09-11 |
2024-03-25 |
Ambrx, Inc. |
Interleukino-2 polipeptido konjugatai ir jų panaudojimas
|
|
WO2020060944A1
(en)
|
2018-09-17 |
2020-03-26 |
Sutro Biopharma, Inc. |
Combination therapies with anti-folate receptor antibody conjugates
|
|
WO2020058372A1
(en)
|
2018-09-19 |
2020-03-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of cancers resistant to immune checkpoint therapy
|
|
JP7546553B2
(ja)
|
2018-09-20 |
2024-09-06 |
レンティジェン・テクノロジー・インコーポレイテッド |
抗ｃｄ１２３免疫療法によりがんを処置するための組成物および方法
|
|
EP3626265A1
(en)
|
2018-09-21 |
2020-03-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Anti-human cd45rc antibodies and uses thereof
|
|
CA3114349A1
(en)
|
2018-09-26 |
2020-04-02 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-cd19/cd22 immunotherapy
|
|
WO2020063676A1
(zh)
|
2018-09-26 |
2020-04-02 |
江苏恒瑞医药股份有限公司 |
依喜替康类似物的配体-药物偶联物及其制备方法和应用
|
|
US20200102399A1
(en)
|
2018-10-01 |
2020-04-02 |
Seattle Genetics, Inc. |
Methods of Treating Peripheral T Cell Lymphoma Using Anti-CD30 Antibody Drug Conjugate Therapy
|
|
SG11202103192RA
(en)
|
2018-10-03 |
2021-04-29 |
Xencor Inc |
Il-12 heterodimeric fc-fusion proteins
|
|
AU2019361206A1
(en)
|
2018-10-19 |
2021-06-03 |
Ambrx, Inc. |
Interleukin-10 polypeptide conjugates, dimers thereof, and their uses
|
|
TWI824043B
(zh)
|
2018-10-25 |
2023-12-01 |
西班牙商瑪製藥股份有限公司 |
藥物抗體共軛物
|
|
EP3873534A1
(en)
|
2018-10-29 |
2021-09-08 |
Mersana Therapeutics, Inc. |
Cysteine engineered antibody-drug conjugates with peptide-containing linkers
|
|
TWI844571B
(zh)
|
2018-10-30 |
2024-06-11 |
丹麥商珍美寶股份有限公司 |
使用抗血管內皮生長因子（ｖｅｇｆ）抗體與抗組織因子（ｔｆ）抗體－藥物共軛體之組合以治療癌症之方法
|
|
EP3882261A4
(en)
|
2018-10-31 |
2023-02-08 |
Ajinomoto Co., Inc. |
COMPOUND COMPRISING A SUBSTANCE HAVING AN AFFINITY FOR AN ANTIBODY, CLEAVAGE SITE AND CORRESPONDING REACTIVE GROUP OR SALT
|
|
EP3647419A1
(en)
|
2018-11-02 |
2020-05-06 |
NBE Therapeutics AG |
Sortase f and its use in methods for conjugation
|
|
EP3877413A1
(en)
|
2018-11-06 |
2021-09-15 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of acute myeloid leukemia by eradicating leukemic stem cells
|
|
CA3119467A1
(en)
|
2018-11-20 |
2020-05-28 |
Cornell University |
Macrocyclic complexes of radionuclides and their use in radiotherapy of cancer
|
|
JP7583720B2
(ja)
|
2018-11-30 |
2024-11-14 |
レンティジェン・テクノロジー・インコーポレイテッド |
抗ｃｄ３８免疫療法によりがんを処置するための組成物および方法
|
|
CA3121573A1
(en)
|
2018-12-03 |
2020-06-11 |
Agensys, Inc. |
Pharmaceutical compositions comprising anti-191p4d12 antibody drug conjugates and methods of use thereof
|
|
KR20210100668A
(ko)
|
2018-12-06 |
2021-08-17 |
제넨테크, 인크. |
항-CD79b 면역접합체, 알킬화제 및 항-CD20 항체를 포함하는 미만성 큰 B-세포 림프종의 조합 요법
|
|
EP3894427A1
(en)
|
2018-12-10 |
2021-10-20 |
Genentech, Inc. |
Photocrosslinking peptides for site specific conjugation to fc-containing proteins
|
|
US20220064260A1
(en)
|
2018-12-14 |
2022-03-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Isolated mhc-derived human peptides and uses thereof for stimulating and activating the suppressive function of cd8+cd45rclow tregs
|
|
WO2020127411A1
(en)
|
2018-12-19 |
2020-06-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and compositions for treating cancers by immuno-modulation using antibodies against cathespin-d
|
|
GB201820864D0
(en)
*
|
2018-12-20 |
2019-02-06 |
J A Kemp |
Antibody-drug conjugates
|
|
WO2020127968A1
(en)
|
2018-12-20 |
2020-06-25 |
Marino Stephen F |
Protein-drug conjugate comprising a monomeric form of proteinase 3
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
CN116063520A
(zh)
|
2019-01-30 |
2023-05-05 |
真和制药有限公司 |
抗gal3抗体及其用途
|
|
WO2020163225A1
(en)
|
2019-02-05 |
2020-08-13 |
Seattle Genetics, Inc. |
Anti-cd228 antibodies and antibody-drug conjugates
|
|
US12109273B2
(en)
|
2019-02-15 |
2024-10-08 |
Wuxi Xdc Singapore Private Limited |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
US11478553B2
(en)
|
2019-02-15 |
2022-10-25 |
Wuxi Biologies Ireland Limited |
Process for preparing antibody-drug conjugates with improved homogeneity
|
|
CN109652384B
(zh)
*
|
2019-02-21 |
2021-10-26 |
昆明理工大学 |
一种体外培养戊型肝炎病毒的方法
|
|
EP4378958A3
(en)
|
2019-02-26 |
2024-09-04 |
Inspirna, Inc. |
High-affinity anti-mertk antibodies and uses thereof
|
|
MX2021010390A
(es)
|
2019-03-01 |
2021-11-17 |
Xencor Inc |
Anticuerpos heterodimericos que se unen a enpp3 y cd3.
|
|
US11969443B2
(en)
|
2019-03-06 |
2024-04-30 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with self-driving chimeric antigen receptors
|
|
MX2021010477A
(es)
|
2019-03-15 |
2021-10-01 |
Medimmune Ltd |
Dimeros de azetidobenzodiazepina y conjugados que los comprenden para uso en el tratamiento de cancer.
|
|
WO2020187998A1
(en)
|
2019-03-19 |
2020-09-24 |
Fundació Privada Institut D'investigació Oncològica De Vall Hebron |
Combination therapy with omomyc and an antibody binding pd-1 or ctla-4 for the treatment of cancer
|
|
BR112021018608A2
(pt)
|
2019-03-20 |
2021-11-23 |
Univ California |
Anticorpos para claudina-6 e conjugados de fármaco
|
|
EP3941944A4
(en)
|
2019-03-20 |
2022-11-30 |
The Regents of the University of California |
Claudin-6 bispecific antibodies
|
|
WO2020213084A1
(en)
|
2019-04-17 |
2020-10-22 |
Keio University |
Anti aqp3 monoclonal antibody specifically binding to extracellular domain of aquaporin 3 (aqp3) and use thereof
|
|
WO2020227105A1
(en)
|
2019-05-03 |
2020-11-12 |
Sutro Biopharma, Inc. |
Anti-bcma antibody conjugates
|
|
JP7620569B2
(ja)
|
2019-05-06 |
2025-01-23 |
セーキョー |
がん治療のための新規治療用ベクター及びプロドラッグ
|
|
EP3968993A1
(en)
|
2019-05-14 |
2022-03-23 |
F. Hoffmann-La Roche AG |
Methods of using anti-cd79b immunoconjugates to treat follicular lymphoma
|
|
CN120097929A
(zh)
|
2019-05-20 |
2025-06-06 |
因多塞特股份有限公司 |
制备psma缀合物的方法
|
|
EP3972993A1
(en)
|
2019-05-21 |
2022-03-30 |
Novartis AG |
Variant cd58 domains and uses thereof
|
|
EP3972998A1
(en)
|
2019-05-21 |
2022-03-30 |
Novartis AG |
Cd19 binding molecules and uses thereof
|
|
US11052112B2
(en)
|
2019-05-30 |
2021-07-06 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-BCMA immunotherapy
|
|
AR119097A1
(es)
|
2019-06-05 |
2021-11-24 |
Seattle Genetics Inc |
Métodos de purificación de anticuerpos enmascarados
|
|
WO2020247572A1
(en)
|
2019-06-05 |
2020-12-10 |
Seattle Genetics, Inc. |
Masked antibody formulations
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
IL289094A
(en)
|
2019-06-17 |
2022-02-01 |
Tagworks Pharmaceuticals B V |
Tetrazines for increasing the speed and yield of the "click release" reaction
|
|
CA3143925A1
(en)
|
2019-06-17 |
2020-12-24 |
Tagworks Pharmaceuticals B.V. |
Compounds for fast and efficient click release
|
|
KR20220031054A
(ko)
|
2019-07-02 |
2022-03-11 |
더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 |
Egfrviii에 결합하는 단일클론 항체 및 이의 용도
|
|
AU2020318975A1
(en)
|
2019-07-22 |
2022-03-17 |
Seagen Inc. |
Humanized anti-LIV1 antibodies for the treatment of cancer
|
|
CN120204384A
(zh)
|
2019-08-06 |
2025-06-27 |
葛兰素史密斯克莱知识产权发展有限公司 |
生物药物组合物和相关方法
|
|
AU2020327000A1
(en)
|
2019-08-08 |
2022-03-31 |
Regeneron Pharmaceuticals, Inc. |
Novel antigen binding molecule formats
|
|
AU2020328507A1
(en)
|
2019-08-12 |
2022-03-17 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating T-cell mediated immune responses through ADCC targeting of CD39 expressing cells
|
|
US20230218774A1
(en)
|
2019-09-05 |
2023-07-13 |
Pharma Mar, S.A. |
Drug antibody conjugates
|
|
BR112022004913A2
(pt)
|
2019-09-18 |
2022-06-07 |
Baili Bio Chengdu Pharmaceutical Co Ltd |
Derivado de camptotecina e conjugado do mesmo
|
|
EP4031186A1
(en)
|
2019-09-19 |
2022-07-27 |
Seagen Inc. |
Selective drug release from internalized conjugates of biologically active compounds
|
|
MX2022003357A
(es)
|
2019-09-25 |
2022-05-03 |
Seagen Inc |
Combinación de anticuerpo anti-cd30 conjugado con un farmaco, anti-pd-1 y quimioterapia para el tratamiento de cánceres hematopoyéticos.
|
|
US20220362397A1
(en)
|
2019-09-26 |
2022-11-17 |
Nof Corporation |
Heterobifunctional monodispersed polyethylene glycol having peptide linker
|
|
US20220363776A1
(en)
|
2019-10-04 |
2022-11-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical composition for the treatment of ovarian cancer, breast cancer or pancreatic cancer
|
|
EP4038101A2
(en)
|
2019-10-04 |
2022-08-10 |
Seagen Inc. |
Anti-pd-l1 antibodies and antibody-drug conjugates
|
|
CA3154710A1
(en)
|
2019-10-04 |
2021-04-08 |
TAE Life Sciences |
Antibody compositions comprising fc mutations and site-specific conjugation properties
|
|
CN114786731A
(zh)
|
2019-10-10 |
2022-07-22 |
科达制药股份有限公司 |
治疗眼部病症的方法
|
|
CR20220166A
(es)
|
2019-10-18 |
2022-06-15 |
Genentech Inc |
Métodos para usar inmunoconjugados anti-cd79b para tratar linfoma difuso de linfocitos b grandes
|
|
EP3812008A1
(en)
|
2019-10-23 |
2021-04-28 |
Gamamabs Pharma |
Amh-competitive antagonist antibody
|
|
WO2021080608A1
(en)
|
2019-10-25 |
2021-04-29 |
Medimmune, Llc |
Branched moiety for use in conjugates
|
|
AU2020379735A1
(en)
|
2019-11-05 |
2022-05-26 |
Regeneron Pharmaceuticals, Inc. |
N-terminal SCFV multispecific binding molecules
|
|
CA3155754A1
(en)
|
2019-11-07 |
2021-05-14 |
Reshma Abdulla RANGWALA |
Methods of treating cancer with a combination of an anti-pd-1 antibody and an anti-tissue factor antibody-drug conjugate
|
|
TW202131954A
(zh)
|
2019-11-07 |
2021-09-01 |
丹麥商珍美寶股份有限公司 |
利用鉑類劑與抗組織因子抗體－藥物共軛體之組合來治療癌症之方法
|
|
JP7762718B2
(ja)
|
2019-11-22 |
2025-10-30 |
メディミューン リミテッド |
Ｅ２ユビキチン又はユビキチン様コンジュゲートドメインを含む融合タンパク質並びに特定のタンパク質分解のためのドメインの標的化
|
|
TWI877278B
(zh)
|
2019-12-30 |
2025-03-21 |
美商思進公司 |
以非海藻糖苷化抗－ｃｄ７０抗體治療癌症之方法
|
|
EP4087657A1
(en)
|
2020-01-08 |
2022-11-16 |
Synthis Therapeutics, Inc. |
Alk5 inhibitor conjugates and uses thereof
|
|
WO2021148003A1
(zh)
|
2020-01-22 |
2021-07-29 |
上海森辉医药有限公司 |
艾日布林衍生物的药物偶联物、其制备方法及其在医药上的应用
|
|
EP4114852A1
(en)
|
2020-03-03 |
2023-01-11 |
Sutro Biopharma, Inc. |
Antibodies comprising site-specific glutamine tags, methods of their preparation and methods of their use
|
|
WO2021178896A1
(en)
|
2020-03-06 |
2021-09-10 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
|
KR20220151202A
(ko)
|
2020-03-11 |
2022-11-14 |
암브룩스, 인코포레이티드 |
인터류킨-2 폴리펩타이드 접합체 및 그의 사용 방법
|
|
IL296387B2
(en)
|
2020-03-19 |
2024-08-01 |
Avidity Biosciences Inc |
Preparations and methods for the treatment of facial, back and arm muscle atrophy
|
|
EP4129345A4
(en)
|
2020-03-25 |
2023-11-29 |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. |
PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIBODY-DRUG CONJUGATE AND USE THEREOF
|
|
MX2022011769A
(es)
|
2020-03-25 |
2022-10-18 |
Jiangsu Hengrui Pharmaceuticals Co Ltd |
Metodo de preparacion de medicamento de conjugado de anticuerpo.
|
|
MX2022011880A
(es)
|
2020-03-27 |
2022-10-20 |
Avidity Biosciences Inc |
Composiciones y metodos para tratar distrofia muscular.
|
|
US20230128499A1
(en)
|
2020-03-27 |
2023-04-27 |
Novartis Ag |
Bispecific combination therapy for treating proliferative diseases and autoimmune diseases
|
|
CN115955980A
(zh)
|
2020-04-10 |
2023-04-11 |
思进公司 |
电荷可变接头
|
|
JP2023522259A
(ja)
|
2020-04-21 |
2023-05-29 |
ファルマ、マール、ソシエダード、アノニマ |
薬物抗体コンジュゲート
|
|
BR112022021441A2
(pt)
|
2020-04-24 |
2022-12-13 |
Genentech Inc |
Métodos para tratar linfoma folicular e linfoma difuso de grandes células b e kits
|
|
WO2021221927A1
(en)
|
2020-04-27 |
2021-11-04 |
Parsons Corporation |
Narrowband iq signal obfuscation
|
|
WO2021231976A1
(en)
|
2020-05-14 |
2021-11-18 |
Xencor, Inc. |
Heterodimeric antibodies that bind prostate specific membrane antigen (psma) and cd3
|
|
CN115968377A
(zh)
|
2020-05-20 |
2023-04-14 |
居里研究所 |
单域抗体及其在癌症治疗中的用途
|
|
CN116157151A
(zh)
|
2020-05-26 |
2023-05-23 |
真和制药有限公司 |
通过阻断半乳凝素-3治疗炎性疾病的方法
|
|
CN116209461A
(zh)
|
2020-06-05 |
2023-06-02 |
特沙公司 |
Cd-30阳性癌症的治疗
|
|
EP4163294A4
(en)
|
2020-06-09 |
2024-07-24 |
Ajinomoto Co., Inc. |
MODIFIED FERRITIN AND METHOD FOR PRODUCING SAME
|
|
CA3171101A1
(en)
|
2020-06-22 |
2021-12-30 |
Dina SCHNEIDER |
Compositions and methods for treating cancer with tslpr-cd19 or tslpr-cd22 immunotherapy
|
|
EP4171652A1
(en)
|
2020-06-29 |
2023-05-03 |
Genmab A/S |
Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer
|
|
US20230323299A1
(en)
|
2020-08-03 |
2023-10-12 |
Inserm (Institut National De La Santé Et De La Recherch Médicale) |
Population of treg cells functionally committed to exert a regulatory activity and their use for adoptive therapy
|
|
EP4192871A1
(en)
|
2020-08-04 |
2023-06-14 |
Seagen Inc. |
Anti-cd228 antibodies and antibody-drug conjugates
|
|
WO2022040482A1
(en)
|
2020-08-19 |
2022-02-24 |
Xencor, Inc. |
Anti-cd28 and/or anti-b7h3 compositions
|
|
CN112062855B
(zh)
|
2020-08-26 |
2024-08-30 |
北京天诺健成医药科技有限公司 |
一种含有衔接器的药物治疗剂的开发和应用
|
|
JP2023542141A
(ja)
|
2020-09-15 |
2023-10-05 |
ザ ユニバーシティー オブ モンタナ |
繊維状バクテリオファージを標的化する組成物および方法
|
|
EP3970752A1
(en)
|
2020-09-17 |
2022-03-23 |
Merck Patent GmbH |
Molecules with solubility tag and related methods
|
|
AU2021349385A1
(en)
|
2020-09-28 |
2023-05-25 |
Seagen Inc. |
Humanized anti-liv1 antibodies for the treatment of cancer
|
|
WO2022079270A1
(en)
|
2020-10-16 |
2022-04-21 |
Université D'aix-Marseille |
Anti-gpc4 single domain antibodies
|
|
CN116801898A
(zh)
|
2020-11-05 |
2023-09-22 |
莱蒂恩技术公司 |
用于用抗cd19/cd22免疫治疗来治疗癌症的组合物和方法
|
|
EP4240415A1
(en)
|
2020-11-08 |
2023-09-13 |
Seagen Inc. |
Combination-therapy antibody drug conjugate with immune cell inhibitor
|
|
CN114524878B
(zh)
|
2020-11-23 |
2024-08-02 |
康诺亚生物医药科技（成都）有限公司 |
一种双特异性抗体及其用途
|
|
CN114573703A
(zh)
|
2020-12-02 |
2022-06-03 |
康诺亚生物医药科技（成都）有限公司 |
一种t细胞衔接器治疗剂的开发和应用
|
|
CN114573702A
(zh)
|
2020-12-02 |
2022-06-03 |
康诺亚生物医药科技（成都）有限公司 |
一种新型肿瘤衔接器治疗药物的开发和应用
|
|
US20250270320A1
(en)
|
2020-12-10 |
2025-08-28 |
Eutilex Co., Ltd. |
Anti-pd-1 antibody and uses thereof
|
|
IL303447A
(en)
|
2020-12-23 |
2023-08-01 |
Univ Muenchen Ludwig Maximilians |
Improved cd30 targeting antibody drug conjugates and uses thereof
|
|
CN114685657B
(zh)
|
2020-12-31 |
2024-08-16 |
康诺亚生物医药科技（成都）有限公司 |
一种功能增强型抗体阻断剂的开发及其应用
|
|
CN114716548B
(zh)
|
2021-01-05 |
2024-11-05 |
(株)爱恩德生物 |
抗-fgfr3抗体及其用途
|
|
US20240317890A1
(en)
|
2021-01-14 |
2024-09-26 |
Institut Curie |
Her2 single domain antibodies variants and cars thereof
|
|
JP7670072B2
(ja)
|
2021-01-18 |
2025-04-30 |
味の素株式会社 |
化合物またはその塩、およびそれらにより得られる抗体
|
|
CN116829573A
(zh)
|
2021-01-18 |
2023-09-29 |
味之素株式会社 |
化合物或其盐、及由它们得到的抗体
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
CA3206549A1
(en)
|
2021-01-29 |
2022-08-04 |
Frederick G. Vogt |
Methods of making modified tumor infiltrating lymphocytes and their use in adoptive cell therapy
|
|
WO2022182415A1
(en)
|
2021-02-24 |
2022-09-01 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US20250269046A1
(en)
|
2021-02-26 |
2025-08-28 |
Forschungsverbund Berlin E.V. |
Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives
|
|
US20250326855A1
(en)
|
2021-03-05 |
2025-10-23 |
Go Therapeutics, Inc. |
Anti-glyco-cd44 antibodies and their uses
|
|
CN117157319A
(zh)
|
2021-03-09 |
2023-12-01 |
Xencor股份有限公司 |
结合cd3和cldn6的异二聚抗体
|
|
KR20230154311A
(ko)
|
2021-03-10 |
2023-11-07 |
젠코어 인코포레이티드 |
Cd3 및 gpc3에 결합하는 이종이량체 항체
|
|
CN116964076A
(zh)
|
2021-03-11 |
2023-10-27 |
味之素株式会社 |
化合物或其盐、以及由它们得到的抗体
|
|
JPWO2022196675A1
(enExample)
|
2021-03-16 |
2022-09-22 |
|
|
|
MX2023010819A
(es)
|
2021-03-18 |
2023-09-28 |
Seagen Inc |
Liberacion selectiva de farmacos a partir de conjugados internalizados de compuestos biologicamente activos.
|
|
US12036286B2
(en)
|
2021-03-18 |
2024-07-16 |
Seagen Inc. |
Selective drug release from internalized conjugates of biologically active compounds
|
|
JP2024512567A
(ja)
|
2021-03-23 |
2024-03-19 |
インサーム（インスティテュ ナシオナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシェ メディカル） |
Ｔ細胞リンパ腫の診断および治療方法
|
|
WO2022211075A1
(ja)
|
2021-03-31 |
2022-10-06 |
日本マイクロバイオファーマ株式会社 |
抗体薬物複合体の製造方法及びそれに用いる酵素
|
|
US20240382592A1
(en)
|
2021-04-09 |
2024-11-21 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the treatment of anaplastic large cell lymphoma
|
|
AU2022253902A1
(en)
|
2021-04-10 |
2023-11-02 |
Genmab A/S |
Folr1 binding agents, conjugates thereof and methods of using the same
|
|
AU2022262606A1
(en)
|
2021-04-21 |
2023-11-09 |
Indapta Therapeutics, Inc. |
Methods of treatment and dosing of natural killer cell compositions
|
|
TW202308699A
(zh)
|
2021-04-23 |
2023-03-01 |
美商普方生物製藥美國公司 |
Ｃｄ７０結合劑、其結合物及其使用方法
|
|
CN117545511A
(zh)
|
2021-04-23 |
2024-02-09 |
柏林合作研究学会 |
与不饱和磷(v)化合物的硫醇偶联
|
|
CN117529551A
(zh)
|
2021-04-27 |
2024-02-06 |
贝勒医学院 |
表达嵌合抗原受体的病毒特异性免疫细胞
|
|
US11931420B2
(en)
|
2021-04-30 |
2024-03-19 |
Celgene Corporation |
Combination therapies using an anti-BCMA antibody drug conjugate (ADC) in combination with a gamma secretase inhibitor (GSI)
|
|
AU2022273063A1
(en)
|
2021-05-12 |
2023-11-23 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
EP4346882A1
(en)
|
2021-05-26 |
2024-04-10 |
Oxford BioTherapeutics Ltd |
Pharmaceutical combination comprising an anti-cd205 antibody and an immune checkpoint inhibitor
|
|
TW202320857A
(zh)
|
2021-07-06 |
2023-06-01 |
美商普方生物製藥美國公司 |
連接子、藥物連接子及其結合物及其使用方法
|
|
US20250026838A1
(en)
|
2021-07-13 |
2025-01-23 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
US20240352080A1
(en)
|
2021-07-14 |
2024-10-24 |
Seagen Inc. |
Antibody Masking Domains
|
|
WO2023012669A2
(en)
|
2021-08-03 |
2023-02-09 |
Glaxosmithkline Intellectual Property Development Limited |
Biopharmaceutical compositions and stable isotope labeling peptide mapping method
|
|
KR20240107093A
(ko)
|
2021-08-05 |
2024-07-08 |
고 테라퓨틱스, 인크. |
항-글리코-muc4 항체 및 그의 용도
|
|
US20240336697A1
(en)
|
2021-08-07 |
2024-10-10 |
Genentech, Inc. |
Methods of using anti-cd79b immunoconjugates to treat diffuse large b-cell lymphoma
|
|
EP4400121A1
(en)
|
2021-09-03 |
2024-07-17 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
|
TW202328188A
(zh)
|
2021-09-03 |
2023-07-16 |
美商Ｇｏ治療公司 |
抗醣化-cmet抗體及其用途
|
|
AU2022339819A1
(en)
|
2021-09-03 |
2024-04-11 |
Go Therapeutics, Inc. |
Anti-glyco-lamp1 antibodies and their uses
|
|
US20250327057A1
(en)
|
2021-09-06 |
2025-10-23 |
Veraxa Biotech Gmbh |
Novel aminoacyl-trna synthetase variants for genetic code expansion in eukaryotes
|
|
FR3126982B1
(fr)
|
2021-09-14 |
2023-09-15 |
Centre Nat Rech Scient |
Vecteurs ciblant la beta-d-n-acetylglucosaminidase
|
|
KR20240055874A
(ko)
|
2021-09-16 |
2024-04-29 |
어비디티 바이오사이언시스 인크. |
안면견갑상완 근이영양증을 치료하는 조성물 및 방법
|
|
CA3231944A1
(en)
|
2021-09-16 |
2023-03-23 |
Carole GUILLONNEAU |
Anti-human cd45rc binding domains and uses thereof
|
|
EP4405387A1
(en)
|
2021-09-24 |
2024-07-31 |
Seagen Inc. |
Improved antibody masking domains
|
|
CN115975030B
(zh)
|
2021-09-30 |
2023-09-26 |
杭州邦顺制药有限公司 |
抗cd39抗体-药物偶联物及其用途
|
|
CN118119640A
(zh)
|
2021-09-30 |
2024-05-31 |
味之素株式会社 |
抗体和功能性物质的位点选择性的缀合物或其盐、以及其制造中使用的抗体衍生物和化合物或它们的盐
|
|
EP4410830A1
(en)
|
2021-09-30 |
2024-08-07 |
Ajinomoto Co., Inc. |
Conjugate of antibody and functional substance or salt thereof, and antibody derivative and compound or salts thereof to be used in producing conjugate or salt thereof
|
|
TW202321443A
(zh)
|
2021-10-26 |
2023-06-01 |
新加坡商泰莎治療有限公司 |
用於生產編碼car之反轉錄病毒載體的細胞株
|
|
WO2022078524A2
(en)
|
2021-11-03 |
2022-04-21 |
Hangzhou Dac Biotech Co., Ltd. |
Specific conjugation of an antibody
|
|
IL312677A
(en)
|
2021-11-09 |
2024-07-01 |
Tubulis Gmbh |
Conjugates including phosphorus (V) and a camptothecin component
|
|
US20230279120A1
(en)
|
2021-11-09 |
2023-09-07 |
Truebinding, Inc. |
Methods of treating or inhibiting cardiovascular diseases
|
|
IL312675A
(en)
|
2021-11-09 |
2024-07-01 |
Tubulis Gmbh |
Conjugates involving phosphorus (V) and a drug component
|
|
WO2023089314A1
(en)
|
2021-11-18 |
2023-05-25 |
Oxford Biotherapeutics Limited |
Pharmaceutical combinations
|
|
WO2023092099A1
(en)
|
2021-11-19 |
2023-05-25 |
Ardeagen Corporation |
Gpc3 binding agents, conjugates thereof and methods of using the same
|
|
DK4186529T3
(da)
|
2021-11-25 |
2025-08-25 |
Veraxa Biotech Gmbh |
Forbedrede antistof-payload-konjugater (apc) fremstillet ved stedspecifik konjugering ved hjælp af genetisk kodeudvidelse
|
|
CA3238627A1
(en)
|
2021-11-25 |
2023-06-01 |
Christine Kohler |
Improved antibody-payload conjugates (apcs) prepared by site-specific conjugation utilizing genetic code expansion
|
|
US20250135011A1
(en)
|
2021-12-08 |
2025-05-01 |
European Molecular Biology Laboratory |
Hydrophilic tetrazine-functionalized payloads for preparation of targeting conjugates
|
|
WO2023104910A1
(en)
|
2021-12-08 |
2023-06-15 |
Tessa Therapeutics Ltd. |
Treatment of lymphoma
|
|
WO2023110937A1
(en)
|
2021-12-14 |
2023-06-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Depletion of nk cells for the treatment of adverse post-ischemic cardiac remodeling
|
|
JP2025504908A
(ja)
|
2022-01-28 |
2025-02-19 |
アイオバンス バイオセラピューティクス，インコーポレイテッド |
サイトカイン関連腫瘍浸潤リンパ球組成物及び方法
|
|
EP4472740A1
(en)
|
2022-01-31 |
2024-12-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Cd38 as a biomarker and biotarget in t-cell lymphomas
|
|
EP4314031B1
(en)
|
2022-02-15 |
2024-03-13 |
Tagworks Pharmaceuticals B.V. |
Masked il12 protein
|
|
US11590169B1
(en)
|
2022-03-02 |
2023-02-28 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with anti-CD123 immunotherapy
|
|
US20230338424A1
(en)
|
2022-03-02 |
2023-10-26 |
Lentigen Technology, Inc. |
Compositions and Methods for Treating Cancer with Anti-CD123 Immunotherapy
|
|
JP2025514669A
(ja)
|
2022-04-11 |
2025-05-09 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Ｔ細胞悪性腫瘍の診断及び処置のための方法
|
|
WO2023198744A1
(en)
|
2022-04-13 |
2023-10-19 |
Tessa Therapeutics Ltd. |
Therapeutic t cell product
|
|
WO2023198874A1
(en)
|
2022-04-15 |
2023-10-19 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of t cell-lymphomas
|
|
TW202400647A
(zh)
|
2022-04-29 |
2024-01-01 |
美商普瑞諾生物科技公司 |
用於治療嗜酸性球驅動之疾病及病症的方法及組成物
|
|
US20250302982A1
(en)
|
2022-05-06 |
2025-10-02 |
Genmab A/S |
Methods of treating cancer with anti-tissue factor antibody-drug conjugates
|
|
KR20250042144A
(ko)
|
2022-06-27 |
2025-03-26 |
포어신 테크놀로지 (베이징) 컴퍼니., 리미티드. |
Itga2를 표적으로 하는 항체 및 이를 포함하는 항체-약물 접합체(antibody targeting itga2 and antibody-drug conjugate comprising the same)
|
|
KR20250043602A
(ko)
|
2022-06-30 |
2025-03-28 |
서트로 바이오파마, 인크. |
항-ror1 항체 및 항체 접합체, 항-ror1 항체 또는 항체 접합체를 포함하는 조성물, 및 항-ror1 항체 및 항체 접합체의 제조 및 사용 방법
|
|
EP4548932A1
(en)
|
2022-06-30 |
2025-05-07 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
|
WO2024003310A1
(en)
|
2022-06-30 |
2024-01-04 |
Institut National de la Santé et de la Recherche Médicale |
Methods for the diagnosis and treatment of acute lymphoblastic leukemia
|
|
KR20250049569A
(ko)
|
2022-07-15 |
2025-04-11 |
페온 테라퓨틱스 리미티드 |
항체-약물 접합체
|
|
JP2025526336A
(ja)
|
2022-07-22 |
2025-08-13 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
Ｔ細胞悪性腫瘍におけるバイオマーカー及びバイオターゲットとしてのｇａｒｐ
|
|
AU2023313641A1
(en)
|
2022-07-26 |
2025-03-13 |
Aimed Bio Inc. |
Anti-ror1 antibody and use thereof
|
|
CN119923410A
(zh)
|
2022-07-28 |
2025-05-02 |
莱蒂恩技术公司 |
用于治疗实体瘤的嵌合抗原受体治疗
|
|
WO2024023283A1
(en)
|
2022-07-29 |
2024-02-01 |
Institut National de la Santé et de la Recherche Médicale |
Lrrc33 as a biomarker and biotarget in cutaneous t-cell lymphomas
|
|
EP4536699A4
(en)
*
|
2022-08-22 |
2025-10-01 |
Suzhou Bioreinno Biotechnology Ltd Company |
METHOD FOR PREPARING AN ANTIBODY HAVING SPECIFIC MODIFICATIONS AT A THIOL GROUP SITE AND USE OF TCEP
|
|
JP2025527006A
(ja)
*
|
2022-08-22 |
2025-08-15 |
スージョウ バイオレイノ バイオテクノロジー リミテッド カンパニー |
部位特異的修飾を有する抗体の調製方法
|
|
EP4577571A1
(en)
|
2022-08-26 |
2025-07-02 |
Lentigen Technology, Inc. |
Compositions and methods for treating cancer with fully human anti-cd20/cd19 immunotherapy
|
|
JP2025511436A
(ja)
|
2022-09-02 |
2025-04-16 |
メルク・シャープ・アンド・ドーム・エルエルシー |
エキサテカン由来トポイソメラーゼ－１阻害薬医薬組成物及びその使用
|
|
AR130536A1
(es)
|
2022-09-21 |
2024-12-18 |
Seagen Inc |
Anticuerpos que se unen a cd228
|
|
WO2024080872A1
(en)
|
2022-10-12 |
2024-04-18 |
Tagworks Pharmaceuticals B.V. |
Strained bicyclononenes
|
|
EP4602372A1
(en)
|
2022-10-12 |
2025-08-20 |
Institut National de la Santé et de la Recherche Médicale |
Cd81 as a biomarker and biotarget in t-cell malignancies
|
|
CN120112312A
(zh)
|
2022-10-18 |
2025-06-06 |
Tubulis 股份有限公司 |
新型抗-tpbg抗体和基于其的抗体-药物偶联物、其治疗方法及用途
|
|
JP2025536308A
(ja)
|
2022-10-18 |
2025-11-05 |
テューブリス ゲーエムベーハー |
新規なＮａＰｉ２ｂ抗体を有する新規な抗体－薬物コンジュゲート、治療的方法、ならびにそれらの使用
|
|
JP2025523332A
(ja)
|
2022-10-25 |
2025-07-23 |
メルク・シャープ・アンド・ドーム・エルエルシー |
エキサテカン由来ａｄｃリンカー－ペイロード、医薬組成物、及びそれの使用
|
|
KR20250089547A
(ko)
|
2022-10-25 |
2025-06-18 |
펩토믹, 에스.엘. |
암 치료를 위한 조합 요법
|
|
AU2023372538A1
(en)
|
2022-11-03 |
2025-05-01 |
Seagen Inc. |
Anti-avb6 antibodies and antibody-drug conjugates and their use in the treatment of cancer
|
|
AU2023396827A1
(en)
|
2022-12-13 |
2025-06-19 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin subtype-2 receptor (sst2r) targeted therapeutics and uses thereof
|
|
WO2024129756A1
(en)
|
2022-12-13 |
2024-06-20 |
Seagen Inc. |
Site-specific engineered cysteine antibody drug conjugates
|
|
AU2023397331A1
(en)
|
2022-12-14 |
2025-06-26 |
Merck Sharp & Dohme Llc |
Auristatin linker-payloads, pharmaceutical compositions, and uses thereof
|
|
GB202219154D0
(en)
|
2022-12-19 |
2023-02-01 |
Metacurum Biotech Ab |
Antibodies and uses thereof
|
|
IL321506A
(en)
|
2022-12-22 |
2025-08-01 |
Tubulis Gmbh |
Conjugates comprising a phosphorus(v) moiety and a drug
|
|
EP4649092A1
(en)
|
2023-01-13 |
2025-11-19 |
Regeneron Pharmaceuticals, Inc. |
Fgfr3 binding molecules and methods of use thereof
|
|
CN120569216A
(zh)
|
2023-01-20 |
2025-08-29 |
巴斯夫欧洲公司 |
稳定型生物聚合物组合物、其制造和用途
|
|
WO2024165484A1
(en)
|
2023-02-06 |
2024-08-15 |
Institut National de la Santé et de la Recherche Médicale |
Enrichment of genetically modified hematopoietic stem cells through multiplex base editing
|
|
AR131815A1
(es)
|
2023-02-09 |
2025-05-07 |
Beigene Ltd |
Conjugados de enlace autoestabilizantes
|
|
WO2024170543A1
(en)
|
2023-02-14 |
2024-08-22 |
Institut National de la Santé et de la Recherche Médicale |
Anti-cd44 antibodies and uses thereof
|
|
AU2024237490A1
(en)
|
2023-03-10 |
2025-09-25 |
Tagworks Pharmaceuticals B.V. |
Trans-cyclooctene with improved t-linker
|
|
WO2024197151A2
(en)
|
2023-03-22 |
2024-09-26 |
Salubris Biotherapeutics, Inc. |
Anti-5t4 antigen binding domains, antibody-drug conjugates and methods of use thereof
|
|
WO2024194851A1
(en)
|
2023-03-23 |
2024-09-26 |
Beigene Switzerland Gmbh |
Bioactive conjugate, preparation method therefor and use thereof
|
|
WO2024206738A1
(en)
|
2023-03-31 |
2024-10-03 |
Immunai Inc. |
Humanized anti-trem2 antibodies
|
|
AU2024243661A1
(en)
|
2023-04-04 |
2025-11-06 |
Ajinomoto Co., Inc. |
Antibody-functional substance conjugate, antibody derivative, and compound, or salts thereof
|
|
WO2024210178A1
(ja)
|
2023-04-05 |
2024-10-10 |
味の素株式会社 |
抗体および機能性物質のコンジュゲートまたはその塩、ならびにチオール基を有する抗体中間体またはその塩
|
|
CN116239513B
(zh)
*
|
2023-05-05 |
2023-08-18 |
天津凯莱英制药有限公司 |
Mmae关键中间体的制备方法、mmae的制备方法和抗体偶联药物
|
|
WO2024230756A1
(zh)
|
2023-05-09 |
2024-11-14 |
上海复宏汉霖生物技术股份有限公司 |
一种抗表皮生长因子受体(egfr)抗体-药物偶联物及其应用
|
|
WO2024236156A1
(en)
|
2023-05-17 |
2024-11-21 |
Institut National de la Santé et de la Recherche Médicale |
Anti-cathepsin-d antibodies
|
|
TW202502371A
(zh)
|
2023-06-07 |
2025-01-16 |
瓦爾希伯倫私人腫瘤研究基金會 |
用於治療癌症的與ｂｒａｆ抑制劑的組合療法
|
|
WO2024251846A1
(en)
|
2023-06-07 |
2024-12-12 |
Fundació Privada Institut D'investigació Oncològica De Vall Hebron |
Combination therapy with mek inhibitors for the treatment of cancer
|
|
EP4473974A1
(en)
|
2023-06-07 |
2024-12-11 |
Peptomyc, S.L. |
Omomyc and kras inhibitors combination therapy for the treatment of cancer
|
|
WO2024254455A1
(en)
|
2023-06-08 |
2024-12-12 |
Genentech, Inc. |
Macrophage signatures for diagnostic and therapeutic methods for lymphoma
|
|
WO2024258743A1
(en)
|
2023-06-13 |
2024-12-19 |
Adcentrx Therapeutics, Inc. |
Methods and compositions related to antibodies and antibody drug conjugates (adcs) that bind nectin-4 proteins
|
|
WO2024258967A1
(en)
|
2023-06-13 |
2024-12-19 |
Synthis Therapeutics, Inc. |
Anti-cd5 antibodies and their uses
|
|
EP4477236A1
(en)
|
2023-06-14 |
2024-12-18 |
Inatherys |
Combination therapy for treating a tumor using adc comprising anti-cd71 antibodies and bh3 mimetics
|
|
WO2025014896A1
(en)
|
2023-07-07 |
2025-01-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Humanized 40h3 antibody
|
|
TW202509219A
(zh)
|
2023-07-13 |
2025-03-01 |
美商艾歐凡斯生物治療公司 |
編碼細胞介素之慢病毒載體及其用於製備腫瘤浸潤性淋巴球之用途
|
|
WO2025021928A1
(en)
|
2023-07-25 |
2025-01-30 |
Merck Patent Gmbh |
Iduronidase-cleavable compounds
|
|
WO2025021929A1
(en)
|
2023-07-27 |
2025-01-30 |
Veraxa Biotech Gmbh |
Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
EP4509142A1
(en)
|
2023-08-16 |
2025-02-19 |
Ona Therapeutics S.L. |
Fgfr4 as target in cancer treatment
|
|
WO2025056807A1
(en)
|
2023-09-15 |
2025-03-20 |
Basf Se |
Stabilized biopolymer composition, their manufacture and use
|
|
AU2024201132A1
(en)
|
2023-09-20 |
2025-04-10 |
Uci Therapeutics Inc. |
Anti-mesothelin antibodies and uses thereof
|
|
AR133955A1
(es)
|
2023-09-26 |
2025-11-19 |
Profoundbio Us Co |
Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
|
|
US20250122306A1
(en)
|
2023-10-13 |
2025-04-17 |
Sutro Biopharma, Inc. |
Anti-tissue factor antibodies and antibody conjugates, compositions comprising anti-tissue factor antibodies or antibody conjugates, and methods of making and using anti-tissue factor antibodies and antibody conjugates
|
|
WO2025120015A1
(en)
|
2023-12-06 |
2025-06-12 |
Institut National de la Santé et de la Recherche Médicale |
Cd5 targeting antibodies with depleting and t or b-cell activation effects
|
|
WO2025126157A1
(en)
|
2023-12-15 |
2025-06-19 |
Advesya |
Anti-il-1rap binding domains and antibody-drug conjugates thereof
|
|
US12134635B1
(en)
|
2023-12-29 |
2024-11-05 |
Sonnet BioTherapeutics, Inc. |
Interleukin 18 (IL-18) variants and fusion proteins comprising same
|
|
CN120285215A
(zh)
*
|
2024-01-10 |
2025-07-11 |
成都百利多特生物药业有限责任公司 |
一种自稳定桥环连接单元及其在抗体-药物偶联物中的应用
|
|
US20250296992A1
(en)
|
2024-01-10 |
2025-09-25 |
Genmab A/S |
Slitrk6 binding agents, conjugates thereof and methods of using the same
|
|
WO2025149947A1
(en)
|
2024-01-12 |
2025-07-17 |
Seagen Inc. |
Antibody-drug conjugates
|
|
WO2025149667A1
(en)
|
2024-01-12 |
2025-07-17 |
Pheon Therapeutics Ltd |
Antibody drug conjugates and uses thereof
|
|
WO2025163468A1
(en)
|
2024-01-30 |
2025-08-07 |
Seagen Inc. |
Anti-pd-l1 antibodies and antibody-drug conjugates and their use in the treatment of cancer
|
|
WO2025174248A1
(en)
|
2024-02-16 |
2025-08-21 |
Tagworks Pharmaceuticals B.V. |
Trans-cyclooctenes with "or gate" release
|
|
US20250381289A1
(en)
|
2024-02-29 |
2025-12-18 |
Genmab A/S |
Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same
|
|
WO2025196639A1
(en)
|
2024-03-21 |
2025-09-25 |
Seagen Inc. |
Cd25 antibodies, antibody-drug conjugates, and uses thereof
|
|
EP4624494A1
(en)
|
2024-03-29 |
2025-10-01 |
Institut Curie |
Her2 single domain antibody and uses thereof
|
|
WO2025223455A1
(en)
|
2024-04-24 |
2025-10-30 |
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. |
Anti-ptk7/b7h3 antibodies and uses thereof
|
|
WO2025240335A1
(en)
|
2024-05-13 |
2025-11-20 |
Regeneron Pharmaceuticals, Inc. |
Fgfr3 binding molecules and methods of use thereof
|
|
WO2025238052A1
(en)
|
2024-05-15 |
2025-11-20 |
Institut National de la Santé et de la Recherche Médicale |
Depletion of plasmacytoid dendritic cells for the treatment of respiratory viral infections
|
|
WO2025250825A1
(en)
|
2024-05-30 |
2025-12-04 |
Sutro Biopharma, Inc. |
Anti-trop2 antibodies, compositions comprising anti-trop2 antibodies and methods of making and using anti-trop2 antibodies
|
|
WO2025248500A1
(en)
|
2024-05-31 |
2025-12-04 |
Janssen Biotech, Inc. |
Antibody drug conjugates that target enpp3
|
|
WO2025248097A2
(en)
|
2024-05-31 |
2025-12-04 |
Gamamabs Pharma |
Humanized anti-human her3 antibodies and uses thereof
|
|
WO2025257394A1
(en)
|
2024-06-14 |
2025-12-18 |
BioNTech SE |
Combination therapy for cancer treatment
|